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There are those who say that the human kidney was created to keep the blood pure, or more 
precisely, to keep our internal environment in an ideal balanced state. This I must deny. I grant 
that the human kidney is a marvelous organ, but I cannot grant that it was purposefully 
designed to excrete urine or to regulate the composition of the blood or to sub-serve the 
physiological welfare of Homo sapiens in any sense. Rather I contend that the human kidney 
manufactures the kind of urine that it does, and it maintains the blood in the composition which 
that fluid has, because this kidney has a certain functional architecture; and it owes that 
architecture not to design or foresight or to any plan, but to the fact that the earth is an unstable 
sphere with a fragile crust, to the geologic revolutions that for six hundred million years have 
raised and lowered continents and seas, to the predacious enemies, and heat and cold, and 
storms and droughts; to the unending succession of vicissitudes that have driven the mutant 
vertebrates from sea into fresh water, into desiccated swamps, out upon the dry land, from one 
habitation to another, perpetually in search of the free and independent life, perpetually failing, 
for one reason or another, to find it.  
…let our kidneys fail for even a short time to fulfill their task, and our mental integrity, our 
personality, is destroyed. 
— Homer William Smith  
Figure and quote from the book, 




Kidneys are the central organ for homeostasis for our body systems and composed of around a 
million functional units, the nephrons. Chronically damaged nephrons deteriorate progressively 
towards end stage renal disease (ESRD), owing to the limited regenerative capacity of adult 
mammalian kidneys. The generation of renal cells from human pluripotent stem cells (hPSCs) 
is a promising strategy to develop regenerative therapies for ESRD. In this study, we established 
a protocol to differentiate hPSCs to renal progenitors (RP), capable of producing nephronal cell 
types and structures in vitro and ex vivo. An effective combination of factors obtained after 
intensive screening, was used to create an 8-day-protocol that steered hPSCs to the renal lineage 
by a step-wise process outlining the embryonic milestones in kidney organogenesis. Six days 
after growth factor treatment, a mixture of SIX2+/CITED1+ cells representing metanephric 
mesenchyme and an HOXB7+/GRHL2+ population indicative of ureteric bud progenitors was 
obtained that developed into LGR5+/JAG1+/WT1+ renal vesicle cells by the day 8. Prolonged 
cultivation of these day 8 cells in three inductive media resulted in generation of 
WT1+/PODXL+/SYNPO+ podocyte-precursors, PDGFRß+/DESMIN+/αSMA+-mesangial cells 
and fractions of proximal, distal and collecting duct tubular epithelial cells in vitro. Moreover, 
day 8 cells differentiate spontaneously into renal organoids in culture. The hPSC-derived RP 
gave rise to tubular structures upon culture as a pellet in air-liquid interface and integrated into 
embryonic kidney re-aggregations. Thus, we demonstrate that our protocol generates RP 
reminiscent of nascent nephrons, which can be coaxed into specialized nephronal cell types in 
vitro after 14 days from hPSCs. This simple and rapid method to produce renal cells from a 
common precursor pool in 2D culture provides the basis for scaled-up production of tailored 




Die Homöostase wird maßgeblich durch die Niere, bestehend aus Millionen funktioneller 
Untereinheiten, den Nephronen, aufrechtherhalten. Chronisch geschädigte Nephrone führen zur 
Entwicklung einer terminalen Nierenerkrankung (TNE). Die Erzeugung renaler Zellen aus 
humanen pluripotenten Stammzellen (hPSCs) stellt eine vielversprechende Strategie zur 
regenerativen Therapie und Behandlung von TNE dar. In der vorliegenden Arbeit wurde ein 
Protokoll zur Differenzierung von renalen Vorläufern (RV) aus hPSCs entwickelt, welches 
nephronale Zelltypen und Strukturen in vitro und ex vivo erzeugte. Eine selektierte 
Kombination von Faktoren wurde in diesem 8-Tage-Protokoll genutzt, um die schrittweise 
Differenzierung der hPSCs zu lenken, indem die embryonale Organogenese der Niere 
abgebildet wurde.  Am Tag 6 der Differenzierung konnten SIX2+/CITED1+ Zellen des 
metanephrischen Mesenchyms und HOXB7+/GRHL2+ Zellen, welche auf Vorläufer der 
Ureterknospe hindeuten, nachgewiesen werden. Diese entwickelten sich am Tag 8 weiter zu 
LGR5+/JAG1+/WT1+ renalen Vesikelzellen. Weiterführende Kultivierung in drei 
verschiedenen induktiven Medien führte zu WT1+/PODXL+/SYNPO+ Podozytenvorläufern, 
PDGFRß+/DESMIN+/αSMA+ Mesangialzellen und epithelialen Zellen des proximalen und 
distalen Tubulus sowie des Sammelrohrs. Außerdem bildeten die Tag-8-Vorläuferzellen 
spontan 3D renale Organoide aus. Die RV induzierten tubuläre Strukturen an einer Luft-
Flüssigkeits-Grenzfläche und integrierten sich in embryonale Nierenaggregate. 
Zusammenfassend konnte demnach ein Protokoll entwickelt werden, welches entstehenden 
Nephronen ähnliche RV generierte, die innerhalb von 14 Tagen in spezialisierte nephronale 
Zelltypen differenzierten. Diese einfache Methode, um renale Zellen aus einem gemeinsamen 
Vorläuferpool in einer 2D -Kultur zu erzeugen, schafft die Grundlage für eine Produktion im 
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1.1. The Kidney: In high demand and low supply 
 
Kidney diseases are a dominant problem with high morbidity and mortality rates as well as a 
very high financial burden to the society.  Between 8 and 10% of the adult population have 
some form of kidney damage, and every year millions die prematurely of complications related 
to Chronic Kidney Diseases (CKD). This disease is a continuum of kidney dysfunction 
beginning from mild kidney damage culminating in kidney failure, referred to as end-stage 
renal disease (ESRD). At the end of 2013, there were around 3.2 million patients being treated 
for ESRD worldwide (Facts-European Renal Care Providers Association). In spite of the 
technological and pharmacological advances achieved in the last years for the treatment of 
ESRD patients, survival is still low. Cardiovascular disease has been considered the most 
common cause of death in these patients (Foley et al., 1998) and this may be connected with 
the high prevalence of classic cardiovascular risk factors, which include hypertension, diabetes 
mellitus, dyslipidemia, smoking, and advanced age (Sousa-Martins et al., 2016).  
 
Hemodialysis, widely used during the past half-century, has offered a solution to lengthen the 
survival of ESRD patients. Nonetheless, it is associated with symptoms that affect the daily life, 
and there is evidence that patients consider the health-related quality of life more important than 
survival itself (Mazairac et al., 2012). Another option for ESRD patients is an organ transplant. 
Kidney transplantation offers patients with end-stage renal disease the greatest potential for 
increased longevity and enhanced quality of life; however, the demand for kidneys far exceeds 
the available supply. Dramatic shifts in baseline immunosuppression have resulted in early graft 
survival but do not necessarily benefit in the long term. However, death of transplant recipients 
from cardiovascular disease, infection and cancer remains an important limitation in kidney 
transplantation. Continued success in kidney transplantation will require increased numbers of 
donors, living and deceased, as well as reduction in the primary causes of late transplant loss, 
namely premature patient death with a functioning graft and chronic allograft nephropathy 
(Knoll, 2008).The increasing demand for kidneys provokes the quest for alternative renal 
therapies relying on concepts of regenerative medicine. Several strategies like stimulation of 
resident adult kidney stem cells, mobilization of stem cells from bone marrow to migrate into 





1.1.1. Endogenous repair of the kidney 
 
Kidneys regulate blood pressure through the renin–angiotensin–aldosterone system, 
erythrocyte production through production of erythropoietin, and circulating calcium and 
phosphate levels, in part through the activation of vitamin D. Many of these functions are 
required to be performed constantly and are accomplished by mechanisms of filtration, re-
absorption, and secretion, which take place in the nephron, the functional unit of the kidney. 
Broadly, at one end of the nephron is the renal corpuscle (glomerulus), the filtration unit, 
followed by a segmented epithelial tubule devoted to the recapture of essential filtrate elements 
(Brunskill et al., 2008). Kidney epithelia are exposed to continuous passage of filtrate, and 
thousands of living cells from healthy humans are excreted daily. For instance, counts of 
exfoliated nephron tubular cells numbered ~78,000 cells per hour in men and ~68,000 cells per 
hour in women(Prescott, 1966).  These cells need to be replenished regularly to maintain 
nephron function. Lineage tracing experiments show that a pool of renal tubular cells is poised 
for division and may serve to bastion against intermittent single cell loss or even more 
widespread, catastrophic insults(Vogetseder et al., 2008). In the recent years, several groups 
have isolated human tubule cells that exhibit impressive proliferation capacities in vitro and in 
vivo -when administered to mice with acute kidney injury (AKI), which they termed ‘renal 
tubular progenitors’ (Angelotti et al., 2012; Bussolati et al., 2005; Lindgren et al., 2011; Smeets 
et al., 2013). Bussolati et al. pioneered the use of the haematopoeitic stem cell antigen, cluster 
of differentiation 133 (CD133) in characterizing a fast cycling population contributing to 
repairing the tubule in concert with CD24 and transcription factor PAX2.  
AKI causes nephron tubule cell death and local inflammation, followed by high cell 
proliferation of epithelial cells with or without mesenchymal transition, which restores tubule 
structure and function. While most post-AKI patients recover their baseline renal function, a 
significant number, approximately ~20% of those affected, will go on to develop long term 
illness characterized by an increase in late stage CKD, cardiovascular complications, and 
increased death rates(Palant et al., 2016). 
While tubular progenitors are able to handle AKI, such a response is not suitable for CKD, 
which is characterized by escalating fibrosis initiated by a primary injury (cell loss/ abnormal 
cell behavior) at the glomerulus or tubule. The fibrotic lesions that result from excessive 
proliferation of cells of pericytic origin lead to the emergence of myofibroblasts that propagate 
over many years, causing nephron dysfunction, atrophy, and collapse, coincident with damage 
to the vasculature that magnifies fibrogenesis and propagates a vicious damage cycle (Li and 
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Wingert, 2013). Experimental evidence that abnormal PEC proliferation after glomerular injury 
can lead to maladaptive glomerular lesions that elicit CKD(Smeets et al., 2009a, 2009b). In 
other words, renal fibrosis is a wound injury response gone awry. Clinical administration of 
BMP-7 has been successful in reversing renal fibrosis(Zeisberg and Kalluri, 2008) and the 
administration of angiotensin-converting -enzyme (ACE) inhibitor reversed proteinuria and 
CKD progression in patients with non-diabetic chronic nephropathy(Ruggenenti et al., 1999). 
Evidence from animal models indicated ACE-inhibitor induced changes in glomerular structure 
including podocyte repopulation (Macconi et al., 2009). 
1.1.2. Re-building nephrons for replacement therapy 
As witnessed in the scenario of kidney maintenance and repair in acute or chronic injury, the 
human kidney displays a tendency of compensation by hypertrophy and hyperplasia rather than 
renewal of nephrons or nephrogenesis. Hence, endogenous regeneration cannot be solely relied 
upon for reviving kidney health during AKI/CKD. Although few populations of the nephron 
are regenerated by adult progenitors, is there a possibility to renew a complete nephron? Unlike 
single-cell disorders like diabetes or amyotrophic lateral sclerosis, the challenge with kidney 
failure is the creation of a functional organ composed of about 30 cell types organized in a 
precise three-dimensional structure (Humphreys, 2015). Even after this, how can the host blood 
supply integrate into the graft? How to plumb in the collecting system to existing ureters? In 
humans, as in most mammals, nephron formation is a fetal event with final nephron number set 
before or near birth. Human nephrogenesis ceases around week 36 of gestation (Potter and 
Thierstein, 1943). Moreover, there is a 10-fold variation in nephron number between 
individuals, no capacity to form new nephrons after birth and a clear inverse relationship 
between nephron number and renal disease (. A deeper look at the embryonic development of 
the kidney and its molecular and cellular basis could help understand these anomalies and how 
to build a nephron from the beginning. 
 
1.2. Retracing the origin of the kidney 
The kidney is embryonically derived by the reciprocal interactions of a nephric mesenchyme 
and epithelial tissue derived from a portion of the embryo called the intermediate mesoderm, 
which in turn arises from a mesendodermal population of the tri-laminar embryo. A detailed 






Figure 1: Embryonic events from fertilization to gastrulation (adapted from(Ho and Crabtree, 2010)). 
 
1.2.1. The blastocyst: An embryo on the verge of organogenesis 
Humans are triploblastic necessitating the generation of the germ layers: ectoderm, endoderm, 
and mesoderm, through a process called gastrulation. During gastrulation, pluripotent 
progenitors restrict their fate progressively to one of the three primary germ layers and kick-
start organogenesis with the formation of organ primordia. The inner cell mass of the embryo, 
at the blastocyst stage (Fig.1), forms a 2-layered disc where the lower cell layer is able to 
differentiate into endoderm and the upper layer into ectoderm without cell movement. 
Immediately after the formation of these two primary cell layers, the mesoderm arises by 
invagination and involution of cells from the upper layer. The cells at the surface begin moving 
to the midline where they involute and migrate laterally to form a mesodermal layer between 
the ectoderm and endoderm. A furrow along the longitudinal midline marks the site of this 
involution called the primitive streak (PS) (Fig.1). During gastrulation, cells in the epiblast and 
their descendants are progressively displaced towards the PS where cellular ingression takes 
place (Lawson and Pedersen, 1992; Lawson et al., 1991) and are organized into layers of 
mesodermal cells that constitute the embryonic and extraembryonic mesoderm. The primary 
cell layer ectoderm gives rise to the epidermis, central nervous system, sense organs, neural 
crest and endoderm gives rise to the lining of the digestive and respiratory tracts; liver and 
pancreas. Lastly, the mesoderm gives rise to, the skeleton, muscles, blood vessels, heart, gonads 
and most importantly the kidney, our organ of interest. Therefore, we delve further into 
understanding the mesoderm and its derivatives. 
 
1.2.2. Mesoderm 
Fate-mapping studies of the mesoderm of a gastrulating embryo reveals that cells that are 
destined for the extraembryonic mesoderm constitute the major tissue type in the nascent 
mesodermal layer (Kinder et al., 1999). During embryonic trunk elongation, the nascent 
mesodermal cells divide, continually pushing out daughter cells toward the rostral region. After 
migration, these cells divide into paraxial mesoderm, lateral plate and intermediate mesoderm 
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(Takasato and Little, 2015).The precursors for cranial and heart mesoderm are present later in 
the mesodermal layer of the mid-streak stage embryo, but are ahead of those that contribute to 
the paraxial and lateral mesoderm of the trunk, which form the bulk of the embryonic mesoderm 
in the late-streak embryo (Parameswaran and Tam, 1995; Tam and Behringer, 1997). These 
studies also show that the various mesoderm precursors are distinctly regionalized in the 
mesodermal germ layer and their relative position is concordant with their final location in the 
fetal body. An examination of the regional distribution of PS-derived cells in the paraxial 
mesoderm has revealed that PS cells are allocated to the somites in a cranio-caudal manner(Tam 
and Beddington, 1987).  
 
Figure 2: Constituents of the mesoderm and their derivatives (adapted from Scott.F.Gilbert 2000) 
 
The trunk mesoderm of a neurula stage embryo can be subdivided into four regions 
(Fig.2,(Gilbert, 2000)): 
 The central region of trunk mesoderm is the chorda-mesoderm. This tissue forms the 
notochord, a transient organ whose major functions include inducing and patterning the 
neural tube and establishing the anterior-posterior body axis.  
 Flanking the notochord on both sides is the paraxial, or somitic, mesoderm (PM). The 
tissues developing from this region will be located in the back of the embryo, 
surrounding the spinal cord. The cells in this region will form somites—blocks of 
mesodermal cells on either side of the neural tube—which will produce muscle and 
many of the connective tissues of the back (dermis, muscle, and skeletal elements such 
as the vertebrae and ribs). The anterior-most PM does not segment; it becomes the head 




















connective tissue of the face and skull.  
 The intermediate mesoderm (IM) forms the urogenital system, consisting of the 
kidneys, the gonads, and their associated ducts. The outer (cortical) portion of the 
adrenal gland also derives from this region.  
 Farthest away from the notochord, the lateral plate mesoderm (LPM) gives rise to the 
heart, blood vessels, and blood cells of the circulatory system, as well as to the lining 
of the body cavities. It gives rise to the pelvic and limb skeleton (but not the limb 
muscles, which are somitic in origin). LPM also helps form a series of extraembryonic 
membranes that are important for transporting nutrients to the embryo.  
Along the medio-lateral (center-to-side) axis these four subdivisions are thought to be 
specified by increasing amounts of bone morphogenetic proteins (BMPs) (Pourquié et al., 
1996; Tonegawa et al., 1997). The more lateral mesoderm of the chick embryo expresses 
higher levels of BMP4 than do the midline areas, and one can change the identity of the 
mesodermal tissue by altering BMP expression (Gilbert, 2000). During the development of 
IM, a low level of BMP signaling is required for the formation of the nephric duct and 
nodal/activin expressed by LPM is essential for IM specification (Fleming et al., 2013; 
Obara-Ishihara et al., 1999).The PM appears to be both necessary and sufficient for inducing 
kidney-forming ability in the IM, since co-culturing LPM with PM causes pro-nephric 
tubules to form in the LPM, and no other cell type can accomplish this(Mauch et al., 2000). 
Along the anterior-posterior axis, the determination of the rostral versus caudal fate of the 
IM is governed by opposing gradients of retinoic acid (RA) and fibroblast growth factor 
(FGF) signaling as studied in Xenopus and chick models (Amaya et al., 1993; Duester, 2008; 
Yatskievych et al., 1997). 
 
1.2.3. Intermediate mesoderm 
In the chick embryo, Pax2 and Lim1 are expressed in the IM, starting at the level of the sixth 
somite (i.e., only in the trunk, not in the head). If Pax2 is experimentally induced in the pre-
somitic mesoderm, it converts that paraxial mesoderm into IM, causing it to express Lim1 and 
form kidneys(Mauch et al., 2000). In mice, Lim1 and Pax2 proteins appear to induce one 
another. The anterior border of the Lim1- and Pax2-expressing cells appears to be established 
by the cells above a certain region losing their competence to respond to activin, secreted by 
the neural tube. This competence is established by the transcription factor Hoxb4, which is not 
expressed in the anterior-most region of the intermediate mesoderm(Gilbert, 2000). The 
anterior boundary of Hoxb4 is established by a retinoic acid gradient, and adding activin locally 
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will allow the kidney to extend anteriorly(Barak et al., 2005; Preger-Ben Noon et al., 2009). In 
mice, the transcriptional regulator Osr1 is expressed broadly in the IM mesenchyme beginning 
at E7.5 and its activity is essential for development of multiple IM derived structures (James et 
al., 2006; Wang et al., 2005). Descendents of Osr1+ cells initially contribute to all kidney 
compartments and are restricted to nephron progenitors after E11.5 (Mugford et al., 2008). 
Careful lineage analysis in mouse suggests that the collecting ducts of the kidney arise from 
progeny of the anterior IM which form a Wolffian duct, whereas the nephrons arise from the 
progeny of the posterior IM, the metanephric mesenchyme (Fig.3,(Taguchi et al., 2014)). The 
origin of the vasculogenic endothelial progenitors and the surrounding stromal cells is less 
defined but is also likely to be IM, possibly from the posterior end. Importantly, cells present 
within these anterior and posterior regions are exposed to distinct spatio-temporal 
signals(Taguchi et al., 2014; Takasato and Little, 2015).  
 
 
Figure 3: Novel model for lineage segregation of ureteric bud (UB) and metanephric mesenchyme (MM) proposed 
by Taguchi 2014. 
 
1.2.4. Nephrogenesis 
1.2.4.1. Nephric duct/Wolffian duct 
The nephric duct (ND) is a tubular structure essential for the formation and function of the 
vertebrate excretory and reproductive systems. In mammalian and avian embryos, the ND is 
derived from the “duct primordium,” an aggregate of mesenchymal cells that arises in the 
IM on both sides of the embryo at the axial levels of somites 6–10 (Attia et al., 2012)). 
Subsequently, the duct primordia elongate in a posterior (caudal) direction until they fuse 
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with the cloaca at the caudal end of the embryo. As the ND elongates, the cells that comprise 
it undergo mesenchymal to epithelial transition, and interactions between the duct and 
adjacent mesodermal cells induce formation of the mesonephros (the embryonic/fetal 
kidney) and the metanephros (the adult kidney). The ND itself gives rise to the collecting 
ducts of the kidney and the ureter, which drain urine from the kidney, and in males to the 
spermatic duct. If ND elongation is inhibited, none of these structures are formed (Soueid-
Baumgarten et al., 2014; Waddington, 1938). FGF signaling is required for (non-directional) 
ND migration together with glial-derived neurotrophic factor (GDNF) (Attia et al., 2015; 
Drawbridge et al., 2000). Both FGF-receptors-2 and -3 are initially expressed in the duct, 
although in later embryos only FGFR2 expression can be detected, suggesting that FGFR2 
is more likely to be critical for duct migration(Attia et al., 2015). 
 
1.2.4.2. Pronephros and Mesonephros 
Early in development (day 22 in humans; day 8 in mice), the pronephric duct arises in the 
IM just ventral to the anterior somites. The cells of this duct migrate caudally, and the 
anterior region of the duct induces the adjacent mesenchyme to form the pronephros, or 
tubules of the initial kidney (Fig.4(Romagnani et al., 2013)). The pronephric tubules form 
functioning kidneys in fish and in amphibian larvae, but they are not active in amniotes. In 
mammals, the pronephric tubules and the anterior portion of the pronephric duct degenerate, 
but the more caudal portions of the pronephric duct persist as the ND and serve as the central 
component of the excretory system throughout development (Saxén and Sariola, 1987). As 
the pronephric tubules degenerate, the middle portion of the ND induces a new set of kidney 








The human mesonephros begins to develop in the fourth week of gestation and contains well-
developed nephrons comprising vascularized glomeruli connected to proximal and distal type 
tubules draining into the mesonephric duct, itself a continuation of the pronephric duct. The 
mesonephric duct extends to fuse with the cloaca, the urinary bladder precursor, at the end of 
the fourth week. In some mammalian species, the mesonephros functions briefly in urine 
filtration, but in mice and rats it does not function as a working kidney. In humans, about 30 
mesonephric tubules form, beginning around day 25(Woolf and Pitera, 2009). The pronephros 
and mesonephros can be regarded as a single unit, and as the wave of differentiation spreads 
caudally, the cranial end of this organ complex begins to regress. While it remains unknown, 
whether the human mesonephros actually filters blood and makes urine, it is one of the main 
sources of the hematopoietic stem cells necessary for blood cell development(Medvinsky and 
Dzierzak, 1996; Wintour et al., 1996). Second, in male mammals, some of the mesonephric 
tubules persist to become the tubes that transport the sperm from the testes to the urethra (the 
epididymis and vas deferens (Gilbert, 2000).  
 
1.2.4.3. Metanephros 
The metanephros is the last embryonic kidney to develop and represents the functioning kidney 
in humans. It consists of two components. These are the ureteric bud (UB) epithelium, which 
branches from the caudal part of the mesonephric duct around 4 weeks of gestation, and the 
metanephric mesenchyme (MM), which condenses from the IM around the enlarging tip, or 
ampulla, of the bud (Potter 1972,(Woolf and Pitera, 2009)). In humans, the metanephric kidney 
can be identified as an entity around week 5–6 of gestation. The UB and its branches form 
epithelia of the collecting ducts, renal pelvis, ureter and bladder trigone, whereas the MM 
differentiates into nephron tubules (glomerular, proximal tubular, and loop of Henle epithelia). 
The metanephric (permanent) kidney develops by means of a series of iterative branching and 
inductive events between the UB and adjacent MM. Repeated rounds of branching 
morphogenesis and nephron induction occur within the nephrogenic zone, the birthplace of a 
nephron, located at the tip of every ureteric branch (Fig.5).  
 
Three major cellular compartments are represented within the nephrogenic zone:  
(i) A nascent Wnt11+ ureteric tip epithelium which undergoes successive rounds 
of branching, elongation, and differentiation to form the collecting ducts;  
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(ii) A multipotent, self- renewing, nephrogenic progenitor Six2+; Cited1+ cell 
population (Kobayashi et al., 2008; Rothenpieler and Dressler, 1993) (cap 
mesenchyme) that is induced to condense along the surface of the ureteric tips, 
undergo a mesenchymal-to-epithelial transition (MET) and form the nephron 
epithelium; and  
(iii) An outer layer of Foxd1+ mesenchymal stromal/interstitial cells that contribute 




Figure 5: Detailed view of a mouse metanephros. The developing metanephros consists of discrete compartments. 
The renal capsule envelops the kidney and contains capsular stromal cells. The outer cortex (nephrogenic zone) beneath 
the capsule is the site where nephrogenesis is initiated. The inner cortex consists of maturing nephrons. The medulla 
lies interior to the cortex and contains developing tubules that penetrate deep into the kidney tissue. Cellular and 
molecular organization of collecting duct (Wnt11+), nephron (Six2+), interstitial (Foxd1+), and vascular progenitors 
within a ureteric tip niche.(Adapted from (Li et al., 2014; McMahon, 2016))  
 
 
Successive waves of nephron induction in the nephrogenic zone propagate centrifugal growth 
and expansion of the kidney, inwardly displacing older generations of ureteric tips, renal 
vesicles, and stromal progenitors. The nephrogenic progenitor Six2+ cell population also called 
the uninduced MM (uiMM) is highly proliferative and responsive to Fgf9/Fgf20 and Bmp7 
(Fig. 6). These cells are called induced MM (iMM) once they attain a Cited1+ state, and are 
responsive to Wnt9b that coaxes a mesenchymal-epithelial transition generating a Lef1+/Six2- 
population, a pre-tubular aggregate (PTA) stage(Brown et al., 2013). Wnt9b signaling activates 
expression of secondary signals, Fgf8 and a second Wnt member, Wnt4, within PTAs triggering 
the formation of an epithelial structure with a lumen -the precursor of the nephron epithelial 
tube and is called the renal vesicle (RV). (Genes important in these morphogenic events are 




Figure 6: Key inductive events in mammalian kidney morphogenesis Diagram showing the formation of 
the UB as a swelling of the ND which grows towards the MM before undergoing initial bifurcation and the stages of 
nephron maturation from PTA through RV, CSB(Comma-shaped body), SSB (S-shaped body), capillary loop nephron 
and mature nephron. b) Diagram of a nephrogenic niche illustrating the signaling pathways critical for branching (left) 
versus cap mesenchyme self-renewal (top right) and differentiation (bottom right). (Adapted from Little 2015) 
1.2.4.4. Stage I and II nephrons: Renal vesicle and S-shaped body 
The RV represents the point of transition from mesenchyme to a polarized epithelial state. 
Because the kidney expands as a sphere from a central starting point, researchers consider the 
center to peripheral axis as the proximal–distal axis in describing the relative position of 
emerging structures within the MM. Thus, peripheral structures become distal and closer to the 
cortex than to the medulla. Nascent epithelial structures always appear on the proximal side of 
the UB tip, and their own proximal–distal axis remains aligned, with the duct tip marking the 
distal end (Kopan et al., 2007). Proximal–distal polarity within nascent nephrogenic bodies is 
morphologically apparent in the comma-shaped body, formed because the first cells to elongate, 
change shape, and form a “slit” are located at the proximal end, farthest from the ureteric bud 
(Saxén and Sariola, 1987). Proliferation and differential adhesion may be the drivers that contort 
the comma-shaped body into an S-shaped structure that fuses at its distal end with the UB while 
podocyte precursors emerge at its most proximal end. Variations in the levels of β-catenin 
activity in the nephron, within a gradient are directly responsible for correct patterning, 




Figure 7: Genetic pathways of nephron segmentation in mice. Genes described in Appendix-Table, right panel 
nephron showing G: glomerulus; N: neck; PS1, PS2, and PS3: segments of the proximal tubule, DTL: descending thin 
limb, ATL: ascending thin limb; TAL, thick ascending limb, MD: macula densa, DCT: distal convoluted tubule, CNT: 
connecting tubule; CD: collecting duct (Adapted from (Desgrange and Cereghini, 2015)) 
Several distinct cell-populations form and these produce the different segments of the adult 
nephron(Saxén and Sariola, 1987) as seen in Fig.7; a Wt1+ cell population gives rise to 
proximal structures including the glomerulus and a segment of proximal tubules, a Jag1+ 
population to the medial part- proximal tubules and loop of Henle; and Lgr5+ cells generate the 
distal nephron segments - distal convoluted tubules (Barker et al., 2012; Chen and Al-Awqati, 
2005; Cheng et al., 2007; Kreidberg, 2010). These segments are in turn further subdivided into 
functionally specialized portions of the adult nephron, which express specific combinations of 
transmembrane transporters/channels for salts, glucose, and metals (Raciti et al., 2008).  
 
1.2.5. Stage IV: Adult nephron 
1.2.5.1. Corpuscle 
The renal corpuscle is composed of two parts: a tuft of capillaries and mesangial cells called 
glomerulus and a double-walled epithelial capsule called Bowman's capsule. The interior of 
Bowman's capsule (Bowman's space) is continuous with the proximal convoluted tubule. The 
glomerular capillary tuft in each glomerulus arises from the afferent arteriole that brings blood 
to the glomerulus and eventually coalesces to form the efferent arteriole that takes blood away 
from the glomerulus(Kriz and Kaissling, 2013).  
 
Figure 8: Constituent cell types of the nephron [Source: Cellfinder.de] 
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Mesangial cells are modified smooth muscle cells, and lie in between the glomerular capillaries 
(Fig.8 B). They generate extracellular matrix, regulate capillary flow and ultrafiltration surface 
and produce prostaglandins and cytokines. The outer layer of the Bowman's capsule is the outer 
boundary of the renal corpuscle and formed by a single layer of squamous epithelial cells called 
parietal cells. The inner visceral layer of the Bowman's capsule is composed of modified 
epithelial cells known as podocytes, which have foot-like processes called pedicels that wrap 
themselves tightly around endothelial cells of the glomerular capillaries which are fenestrated. 
These pedicels inter-digitate, to form filtration slits, leaving small gaps between the digits to 
form a sieve. The association of the glomerular capillary endothelial cells and podocytes leads 
to the formation of the glomerular filtration barriers (also referred to as the blood-to-urine 
barriers). The filtration barrier is formed by three components: the diaphragms of the filtration 
slits, the thick glomerular basement membrane, and the glycocalyx secreted by podocytes. 
Overall, filtration is regulated by fenestrations in capillary endothelial cells, podocytes with 
filtration slits, membrane charge, and the basement membrane between capillary cells. Any 
proteins that are roughly of molecular weight 30 kDa or under, can pass freely through the 
filtration barrier. Between the visceral and parietal layers is a Bowman's space, into which the 
filtrate enters after passing through the filtration slits of podocytes. Any small molecules such 
as water, glucose, salt (NaCl), amino acids, and urea pass freely into the Bowman's space, but 
cells, platelets and large proteins do not. As blood passes through the glomerulus, 10 to 20 
percent of the plasma filters at the filtration membrane to be captured by the Bowman’s capsule 
and funneled to the proximal convoluted tubule as the glomerular ultra-filtrate(Kriz and 
Kaissling, 2013).  
 
1.2.5.2. Tubulus 
The first part of the renal tubule is called the proximal convoluted tubule (PT), which has 
convoluted early and intermediate segments S1 and S2 in the renal cortex and a straight segment 
S3 that enters the outer medulla. Water and solutes that have passed through the proximal 
convoluted tubule enter the Loop of Henle, which consists of two portions - first the descending 
limb of Henle, then the ascending limb. In order to pass through the Loop of Henle (LOH), the 
water (and substances dissolved in it) pass from the renal cortex into the renal medulla, and 
then back to the renal cortex. When this fluid returns to the renal cortex (via the ascending limb 
of Henle) it passes into the distal convoluted tubule (DT). The fluid that has passed through the 
distal convoluted tubules is drained into the collecting duct. The distal convoluted tubules of 
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many individual kidney nephrons converge onto a single collecting duct that drains into the 
calyces.  
The PT is composed of a single layer of cuboidal epithelial cells equipped with microvilli that 
aid in re-absorbing approximately two-thirds of the filtered salt and water and all filtered 
organic solutes (primarily glucose and amino acids) from the ultra-filtrate into the peritubular 
capillaries. The primary role of the LOH is to concentrate the salt in the interstitium, the tissue 
surrounding the loop. While the descending limb is impermeable to salt, allowing water to be 
transported over the osmotic gradient, the ascending limb is impermeable to water and actively 
pumps sodium out of the filtrate, generating the hypertonic interstitium that drives 
countercurrent exchange. By the time the filtrate reaches the DT, it is hypotonic as a huge 
amount of sodium was lost. Although composed of the same cuboidal epithelial cells as the PT, 
cells of DT have fewer microvilli and mitochondria and are susceptible to endocrine regulation. 
Aldosterone increases the amount of Na+/K+ ATPase in the basal membrane of the DT and 
collecting duct thereby causing sodium to move out of the filtrate. Aldosterone is secreted by 
the adrenal cortex in response to angiotensin II stimulation. Receptors for parathyroid hormone 
(PTH) are found in DT cells and when bound to PTH, induce the insertion of calcium channels 
on their luminal surface thus recovering calcium from the filtrate. Regulation of urine volume 
and osmolarity are major functions of the collecting ducts. By varying the amount of water that 
is recovered, the collecting ducts play a major role in maintaining the body’s normal osmolarity, 
regulated by the anti-diuretic hormone (ADH or vasopressin) secreted by the posterior pituitary. 
When stimulated by ADH, aquaporin channels are inserted into the apical membrane of 
principal cells, which line the collecting ducts allowing water to be osmotically extracted from 
the collecting duct (CD) into the surrounding interstitial space and into the peri-tubular 
capillaries, thereby concentrating the filtrate into urine(Matlin and Caplan, 2013).  
 
In humans, nephrogenesis is complete by 36 weeks. Furthermore, there is no evidence to 
suggest that new nephrons can be formed after this time point. The above sections have defined 
the key steps in nephron development. In order to generate kidney replacements, we need to 
recapitulate nephrogenesis in vitro. Producing all cell types that lead to nephronal cell types 




Figure 9: Developmental milestones in kidney organogenesis. 
1.3. A Toolbox for human embryology – Pluripotent stem cells 
While our knowledge on the structure and function of mature organs is mostly derived from 
animal models, human cadavers, or biopsies, the information we have on embryonic organ 
development is largely derived from various model organisms and from technologies that study 
human embryogenesis in vitro. In 1944, the first human egg was fertilized in vitro(Rock and 
Menkin, 1944). Edwards and Steptoe implanted a fertilized egg into a woman's uterus in 
1977(Steptoe and Edwards, 1978) giving the world its first test tube baby. These scientists were 
also paving the way for a closer observation of human embryonic development. Edwards and 
his team had worked on growing human embryos in vitro, until the blastocyst stage (Edwards 
et al., 1981)before re-implanting the embryo into the uterus. Knowing that in vitro culture was 
a suitable interim step in producing a viable organism spurred the goal of replacing damaged 
organs by transplanting organoids produced in vitro. Key advances in this field included the 
derivation of human embryonic stem cells (hESCs) from the inner cell mass of normal human 
blastocysts(Thomson et al., 1998) and the generation of induced pluripotent stem cells 
(iPSCs)(Takahashi and Yamanaka, 2006; Takahashi et al., 2007). These cells demonstrate 
evidence of stable developmental potential even after prolonged culture forming derivatives of 
all three embryonic germ layers from the progeny of a single cell. A huge advantage of iPSCs 
over ESCs is the possibility to have pluripotent stem cells from every individual, providing an 
opportunity to study and repair genetic disorders at a personal level. Pluripotency has been 
exploited to recapitulate many embryonic processes in vitro, including primitive streak 
formation, neural tube induction, and trophoblast formation, extending to the generation of 
functioning neurons, beating cardiomyocytes, and insulin producing beta cells of the pancreas. 
Major achievements in the field of stem cell biology have been the derivation of a multitude of 
differentiated cell types morphologically similar to their terminally differentiated counterparts 
in vivo, but functionally immature in vitro, that have been intended to be used as regenerative 





1.3.1. Breaking pluripotency 
Humans are triploblastic and thus, develop a tri-laminar embryo upon gastrulation, consisting 
of ectoderm, endoderm, and mesoderm. Several groups have cultured PSCs in a feeder free 
matrix-coated surface and promoted differentiation by adding growth factors and inhibitors to 
this 2D system, while other groups applied inductive media to a 3D system, after the generation 
of a sphere of PSC cells known as an embryoid body (EB). Protocols applying defined time 
periods and concentrations of exposure to inductive agents have allowed for the differentiation 
of endo-, ecto-, or mesodermal lineages and specific cell types. For example, activin signaling 
leads to 80% efficient induction of SOX17+/GSC+/FOXA2+/MIXL1+ definitive endoderm in 
hESC cultures after 5 days of differentiation in 100 ng/ml activin A (D’Amour et al., 2005). In 
another seminal study, sequential treatment of high-density undifferentiated monolayer hESC 
cultures with activin A for 24 h and bone morphogenetic protein 4 (BMP4) for 4 days 
consistently yielded >30% cardiomyocytes (Laflamme et al., 2007). For neural induction of 
hESCs, the growth factors insulin, epidermal growth factor (EGF) and basic fibroblast growth 
factor (bFGF) were added in a chemically defined medium, giving rise to up to 90% PAX6+ 
neural progenitors(Joannides et al., 2007). These studies have proved that while a 
spontaneously differentiating mass of PSC can generate varying proportions of endo- and ecto- 
and mesoderm, targeting signaling pathways prominent in the development of an organ of 
interest in a temporal fashion can promote that particular lineage. Over the years, researchers 
have tested various combinations of cell signaling modifiers to achieve enrichment of tissue-
specific cell types in a heterogeneous population of differentiated PSC progeny (reviewed by 
(Murry and Keller, 2008)). Moreover, the level of enrichment varies with the iPSC or ESC 
used. iPSC that are reprogrammed from a somatic cell type originating from an organ and are 
differentiated to a cell type of the same organ, show higher efficiencies owing to epigenetic 
memory of the source (Hiler et al., 2015). This highlights the need for standardization of 




1.3.2. State of the art in developing kidney cells from PSC  
Unlike other organs, few protocols have been established for the kidney. The kidney exhibits a 
remarkable architectural complexity coupled with the presence of at least 26 different 
specialized cells (Al-Awqati and Oliver, 2002). Based on earlier studies that highlighted 
important molecules and pathways that drive mesodermal and nephron differentiation in model 
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organisms, initial studies of differentiation toward the renal lineage were performed on mouse 
ESC-EBs treated with media containing serum together with multiple combinations of factors 
including activin A, BMP4, BMP7, RA, leukemia inhibiting factor (LIF), and GDNF or UB-
derived conditioned media. These protocols led to the generation of cells expressing markers 
of differentiation, e.g., Pax2 (kidney tubules), Aquaporin-2 (collecting duct principal cells), 
Wt1 (metanephric mesenchyme and podocytes), or Ksp-Cadherin (distal nephron tubules), 
within EBs, which provided evidence of successful renal lineage induction (Bruce et al., 2007; 
Kobayashi et al., 2005b; Morizane et al., 2009; Nishikawa et al., 2012; Ren et al., 2010; Vigneau 
et al., 2007). Although a renal identity was achieved in the examples mentioned before, the 
desired cell types could not be isolated owing to low and varying frequencies of occurrence and 
their functionality was not demonstrated. 
Meanwhile, genetic lineage tracing demonstrated that the induced Six2-expressing cap 
mesenchyme represents a nephron progenitor population that gives rise to all cell types of the 
nephron (Kobayashi et al., 2008). Also, the intermediate mesodermal origin of kidney cells was 
confirmed when Mugford et al., used molecular fate mapping to demonstrate that the majority 
of cell types within the metanephric kidney arise from an Osr1-expressing population within 
the intermediate mesoderm (Mugford et al., 2008). These new findings were considered in 
differentiation protocols to distinguish the exact mesodermal cell sub-type required to enrich 
cultures of PSC-derived renal progeny. For instance, Mae et al developed a robust protocol 
using activin A and Wnt-agonist CHIR99021 for 2 days and sequential treatment with BMP7 
and CHIR99021 for 8 days to obtain 90% OSR1+ cells (Mae et al., 2013). Despite such an 
efficient protocol, the dependence on OSR1 as a population identifier created ambiguity, since 
even though OSR1 is expressed in the intermediate mesoderm, it is also expressed in the earlier 
mesoderm prior its subdivision into paraxial and intermediate domains (Guillaume et al., 2009). 
Moreover, OSR1 is expressed in both the intermediate mesoderm and lateral plate (James and 
Schultheiss, 2003; Wilm et al., 2004). 
 
Additional protocols were developed to induce different cell types within the nephron. Human 
PSC derived podocytes expressing Podocin, Nephrin, and Synaptopodin were generated from 
EBs using treatment with activin A, RA, and BMP7 and plating on gelatin (Song et al., 2012). 
In another study, ~90% AQP1+ proximal tubule cells were obtained by treating a monolayer 
PSC culture with media containing renal epithelial growth medium for 9 days (Kandasamy et 
al., 2015). Recent reports demonstrated stepwise induction of UB and/or MM through 
systematic induction of primitive streak alone, followed by intermediate mesodermal 
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specification (Lam et al., 2014; Taguchi et al., 2014; Takasato et al., 2014; Xia et al., 2013, 
2014). These studies performed thorough characterization of cell types obtained at every stage; 
focusing on obtaining PAX2+ GATA3+ LHX1+ UB cells(Xia et al., 2013) and SIX2+ 
PAX2+GDNF+ HOX11+ WT1+ MM cells(Taguchi et al., 2014). Takasato et al. were able to 
generate UB and MM between 14 and 18 days, whereas Lam et al generated SIX2+ SALL1+ 
WT1+ cap mesenchyme by 8 days and showed the potency of PAX2+ LHX1+ IM cells to 
generate tubule structures that express Lotus lectin and Ksp-Cadherin after 9 days of 
differentiation (Lam et al., 2014; Takasato et al., 2014). 
 Table 1 : Methods of differentiation to renal cell types 
 
 
Partial self-organization of mouse embryonic kidney cells upon their re-aggregation, after 
dissociation was first achieved by Unbekandt and Davies (2010) – an example of an 
architecturally intact kidney in vitro. The novelty of this system was the introduction of a ROCK 
inhibitor, which prevented the dissociation-induced apoptosis within single cell suspensions 
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and facilitated a significant recovery of re-aggregated tissues. The Unbekandt re-aggregation 
method has since then been used as a test system to check the capacity of cells (e.g., PSC-
derived cells) to integrate into forming tubules or glomeruli of the mouse nephron. While this 
method proves the property of test cells to contribute to kidney formation, it cannot provide 
proof of self-organization of PSC-derived renal progenitors. 
 Table 2: Status of lab-grown kidney organoids(Hariharan et al., 2015) 
 
 
To this end, kidney organogenesis from PSC have been reported by Takasato et al., where 18 
days of differentiation of PSC seeded initially on Matrigel, develop an ECAD+ ureteric 
epithelium surrounded by clumps of SIX2+ WT1+ PAX2+ MM cells or JAG1+ CDH6+ renal 
vesicles (Takasato et al., 2014). Lam et al. also observed appearance of tubule-like structures 
positive for Lotus lectin (a proximal tubule marker) from SIX2+ cap mesenchyme cell cultures, 
obtained on day 7 of their differentiation procedure, upon treatment with CHIR99021(Lam et 
al., 2014). This was reminiscent of induced metanephric mesenchyme that responds to Wnt 
signals to undergo mesenchymal-epithelial transition and form renal vesicles in vivo (Park et 
al., 2007; Schmidt-Ott et al., 2007). Meanwhile, the group of Nishinakamura also obtained 
evidence of a slightly different nature. They used PSC in the form of EBs for a differentiation 
protocol that took 8.5 days in mouse ESCs and 14 days in human iPSCs, resulting in SIX2+ 
WT1+ SALL1+ PAX2+ MM cells that could give rise to tubules and podocytes when induced 
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by mouse embryonic spinal cord(Taguchi et al., 2014). These studies are evidence that a 
systematic mirroring of embryonic kidney development in PSC derivatives can lead to the 
formation of organo-typical structures, as summarized in Table 2.  
 
1.4. Research gap 
The last five years have brought us a step closer to develop nephrons in vitro, yet, there is clearly 
a need to enhance protocols to achieve full maturation of nephrons that have on one hand a 
filtering unit and on the other hand an optimal spatial orientation of tubules that trigger their 
functionality in terms of electrolyte transport. Together, these important studies provided proof 
of principle that most, if not all components of the kidney can be induced from PSCs. The PSC-
derived UB cells can be utilized to generate a ureteric tree or PSC-derived MM cells can be 
coaxed to produce S-shaped bodies that undergo proximal distal patterning initiating 
tubulogenesis, giving rise to fetal nephrons in culture. It would also be interesting to use cells 
derived from the Xia and Taguchi protocols to obtain reciprocally interacting UB & MM and 
investigate if they interact in a similar manner as they do in vivo. Since most kidney diseases 
involve the damage and loss of podocytes or hypertrophy of tubular epithelial cells, these cell 
types have a high priority of being derived. On the other hand, the big picture of nephron 
reconstruction requires other specialized cells including mesangial cells, glomerular endothelial 
cells, epithelial cells of the loop of Henle, principal cells and intercalated cells that have not yet 
been procured from PSCs. Induction of terminal differentiation, recapitulation of the 




1.5. Objective of this study 
 
The aim of this project was to establish a rapid and efficient step-wise protocol for directing the 
differentiation of human pluripotent stem cells towards the renal lineage. 
 
 Screening of factors (e.g. growth factors, small molecules, extracellular matrix) to 
identify concentrations, combinations and timely order that direct human 
pluripotent stem cells towards the renal lineage. 
 Characterizing the renal cells derived from the treatment of the newly developed 
protocol. 
 Testing the potency of candidate cell populations that exhibit characteristics of 




List of materials 
Table 3: List of antibodies used for immunoflourescence and flow cytometry 
Name Species Clone Description Company Cat.Nr 
AQP 2 Rabbit polyclonal   Collecting duct Novus Biologicals NB110-74682 
SLC12A3 Rabbit polyclonal   Distal tubule and collecting ducts Novus NBP1-59699 
CK19 Mouse monoclonal 
A53-
B/A2 Loop of Henle Santa Cruz SC-6278 
NKCC2 Rabbit polyclonal   Loop of Henle Santa Cruz SC-133823 
Uromucoid Mouse monoclonal   Loop of Henle (Descending) Abcam AB167678 
CDH16  Rabbit polyclonal   Loop of Henle in medulla Proteintech 15107-1-AP 
PDGFRß Rabbit polyclonal   Mesangial cells Santa Cruz SC -432 
SYNPO Mouse monoclonal G1D4 Podocyte- actin-binding protein Progen 65294 
PODXL  Mouse monoclonal 222328 Podocyte membrane R&D Systems MAB1658 
NPHS1 Goat polyclonal   
Podocyte marker, filtration 
barrier SantaCruz SC -19000 





WT1 Rabbit polyclonal   
Podocytes, metanephric 
mesoderm Santa Cruz SC-192 
VILLIN Mouse monoclonal   Proximal tubule Millipore MAB1671 
Na+/K+-ATPase Rabbit polyclonal   Proximal tubule Abcam AB58475 
AQP 1 Rabbit polyclonal   Proximal tubule Proteintech 20333-1-AP 
CK8 Rabbit polyclonal   Whole nephron Santa Cruz SC -134484 
CK18 Mouse monoclonal DC-10 Whole nephron Santa Cruz SC -6259 
MIXL1 Mouse monoclonal 319919 Definitive mesoderm R&D Systems MAB2610 
SIX2 Mouse monoclonal 3D7 Embryonic cap mesenchyme Abnova (tebu-bio) 
H00010736-
M01 
Brachyury(T) Rabbit polyclonal   Definitive mesoderm Santa Cruz SC -20109 
GSC Goat polyclonal   Definitive mesoderm R&D AF4086 
OSR-1 Rabbit polyclonal   intermediate mesoderm 
LifeSpan 
BioSciences LS-C37923 
PAX2 Rabbit polyclonal   
intermediate 
mesoderm/metanephros Invitrogen 71–6000 
LIM1 Mouse monoclonal   
intermediate 
mesoderm/nephricduct Novus Biologicals NBP2-01926 
ITGA8 Mouse monoclonal 481709 Metanephric mesenchyme R&D FAB6194A 
CITED1 Rabbit polyclonal   Embryonic cap mesenchyme Pierce PA1-24469 
CDH1 Mouse monoclonal   Embryonic cap mesenchyme BD Biosciences 610181 
OCT4 Rabbit polyclonal   Pluripotency 
CellSignaling 
technology 2840S 




Table 4: List of primers used for gene expression analysis 
GENE 





OCT4 TGTCTCCGTCACCACTCT TTCCCAATTCCTTCCTTA Pluripotency 
CMYC GGCTCCTGGCAAAAGGTCA AGTTGTGCTGATGTGTGGAGA Pluripotency 
KLF4 CCCACATGAAGCGACTTCCC CAGGTCCAGGAGATCGTTGAA Pluripotency 
NANOG AAGGTCCCGGTCAAGAAACAG CTTCTGCGTCACACCATTGC Pluripotency 
SOX2 TGGACAGTTACGCGCACAT CGAGTAGGACATGCTGTAGGT Pluripotency 
FOXA2 GGAGCAGCTACTATGCAGAGC CGTGTTCATGCCGTTCATCC Endoderm 
SOX17 GTGGACCGCACGGAATTTG GGAGATTCACACCGGAGTCA Endoderm 
NESTIN TTGCCTGCTACCCTTGAGAC GGGCTCTGATCTCTGCATCTAC Ectoderm 
SOX1 CAGTACAGCCCCATCTCCAAC GCGGGCAAGTACATGCTGA Ectoderm 
ZIC1 CACGCGGGACTTTCTGTTC TGCCCGTTGACCACGTTAG Ectoderm 
T AATTGGTCCAGCCTTGGAAT CGTTGCTCACAGACCACA Mesoderm 
GSC AACGCGGAGAAGTGGAACAAG CTGTCCGAGTCCAAATCGC Mesoderm 
MIXL1 CTGTTCCCCTCTCTCTGAAGA GGCAGAAAAGATGTGTTCCTCC Mesoderm 
OSR1 GCTGTCCACAAGACGCTACA CCAGAGTCAGGCTTCTGGTC Intermediate Mesoderm 
PAX2 AGATTCCCAGAGTGGTGTGG GGGTATGTCTGTGTGCCTGA Intermediate Mesoderm 
LHX1 TCATGCAGGTGAAGCAGTTC TCCAGGGAAGGCAAACTCTA IM, Nephricduct 
RET TATCCTGGGATTCCTCCTGA TCTCCAGGTCTTTGCTGATG Uretericbud 
HOXB7 GTGGACTGTGGGTCTGGACT GAACACGCGAGTGGTAGGTT Uretericbud 
HOXD11 TGGAACGCGAGTTTTTCTTT CTGCAGACGGTCTCTGTTCA Metanephricmesenchyme 
SIX2 AGGAAAGGGAGAACAACGAGAA GGGCTGGATGATGAGTGGT Metanephricmesenchyme 
FOXD1 TGCGGGTCCCTCTATTTATG TAACGCCTGGACCTGAGAAT Stromalcomponentof MM 
EYA1 GGACAGGCACCATACAGCTACC ATGTGCTGGATACGGTGAGCTG Cap mesenchyme 














Table 5: List of materials used in this study 
BUFFER FOR ICC-STAINING MANUFACTURER/SUPPLIER 
BD Perm/Wash™ BD Biosciences, Franklin Lakes (USA) 
BD Cytofix™ Biochrom AG, Berlin (Germany) 
Donkey Serum Sigma Aldrich, St. Gallen (Switzerland) 
  
CHEMICALS/REAGENTS MANUFACTURER/SUPPLIER 
4', 6-diamidino-2-phenylindole (DAPI) Life Tecnologies GmbH, Darmstadt (Germany) 
Agarose Standard Carl Roth GmbH, Karlsruhe (Germany) 
Dimethyl sulfoxide (DMSO) Sigma Aldrich, St. Gallen (Switzerland) 
DNA-Ladder 100 bp (0.1 µg/µl) Solis BioDyne Tartu, (Estonia) 
Ethanol Carl Roth GmbH, Karlsruhe (Germany) 
Formaldehyde Carl Roth GmbH, Karlsruhe (Germany) 
Glutamax Gibco®, Life Technologies GmbH, Darmstadt (Germany) 
Gel Red Biotium, Inc. (USA) 
Gentle Dissociation Reagent StemCell™ Technologies, Grenoble (France) 
Hank´s Balanced Salt Solution (HBSS) Sigma Aldrich, St. Gallen (Switzerland) 
HEPES Buffer Lonza (Switzerland) 
Lithium Chloride Carl Roth GmbH, Karlsruhe (Germany) 
PBS (Dulbecco’s Phosphate Buffered 
Saline) with or without Mg2+/Ca2+ 
Gibco®, Life Technologies GmbH, Darmstadt (Germany) 
TritonX Sigma Aldrich, St. Gallen (Switzerland) 
Trypan blue Gibco®, Life Technologies GmbH, Darmstadt (Germany) 
  
CULTURE DISHES MANUFACTURER/SUPPLIER 
Falcon tubes BD Biosciences, Heidelberg (Germany) 
BD Falcon™ 6-well Multiwell Plate BD Biosciences, Heidelberg (Germany) 
BD Falcon™ 12-well Multiwell Plate BD Biosciences, Heidelberg (Germany) 
BD Falcon™ 24-well Multiwell Plate BD Biosciences, Heidelberg (Germany) 
BD Falcon™ 96-well Multiwell Plate, flat 
bottom 
BD Biosciences, Heidelberg (Germany) 
CellCarrier® 96-well Multiwell Plate Perkin Elmer, Waltham (USA) 
Falcon tubes BD Biosciences, Heidelberg (Germany) 
Transwell plates (6- and 24 well format) Costar, Corning Inc. (USA) 
  
ENZYME MANUFACTURER/SUPPLIER 
Dispase in DMEM/F-12 (1mg/ml) StemCell™ Technologies, Grenoble (France) 
DNase Roche AG (Switzerland) 
StemPro® Accutase® Gibco®, Life Technologies GmbH, Darmstadt (Germany) 




Agarose gel chamber Peqlab, Erlangen (Germany) 
Allegra™ Centrifuge X-22 Beckman Coulter GmbH, Krefeld (Germany) 
BD FACSAria™ III BD Biosciences, Heidelberg (Germany) 
BD LSR Fortessa  BD Biosciences, Heidelberg (Germany) 
Cell Scraper TPP® Techno Plastic Products AG, Trasadingen 
(Switzerland) 
Centrifuge Allegra X15R Beckman Coulter, Krefeld (Germany) 
Cryovials Sigma Aldrich, St. Gallen (Switzerland) 
Gel electrophoresis equipment Peqlab, Erlangen (Germany) 
Freezing Container, Nalgene® Mr. Frosty Thermo Scientific, Dreieich (Germany) 
Heraeus Fresco 211 centrifuge Thermo Scientific, Dreieich (Germany) 
Heraeus Multifuge X3R centrifuge Thermo Scientific, Dreieich (Germany) 
Heraeus Pico 17 centrifuge Thermo Scientific, Dreieich (Germany) 
Incubator 11-13625 BINDER GmbH, Tuttlingen (Germany) 
Mastercycler epgradient S Eppendorf, Hamburg (Germany) 
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Microtubes Eppendorf, Hamburg (Germany) 
NanoDrop 1000 spectrophotometer Peqlab Biotechnology GmbH, Erlangen (Germany) 
Neubauer cell counting chamber Celeromics, Grenoble (France) 
Operetta High Content Screener Perkin Elmer, Waltham (USA) 
PCR cycler Gene Amp PCR System 9700 Peqlab, Erlangen (Germany) 
Phase-Contrast Microscope: Axiovert 
40CFL 
Zeiss, Jena (Germany) 
pH-measurement PB11 Sartorius Stedim Biotech GmbH, Göttingen (Germany) 
Real time-PCR –QuantStudio  
 
Stem cell cutting tool 
Applied Biosystems®, Life Technologies GmbH, Darmstadt 
(Germany) 
Vitrolife (United Kingdom) 
Stereo microscope SMZ 1000 Nikon GmbH, Düsseldorf (Germany) 
Thermomixer 5436 Eppendorf, Hamburg (Germany) 
UV-Gel documentation system NightHawk 
Berthold Technologies GmbH & Co. KG, Bad Wildbad 
(Germany) 
Vortex-2 Genie Scientific Industries, Inc, Ney York (USA) 
Waterbath GFL, Burgwedel (Germany) 
Workstation L226IVF HD Scientific, Wetherill Park (Australia) 
  
MEDIA MANUFACTURER/SUPPLIER 
DMEM/F12 Gibco®, Life Technologies GmbH, Darmstadt (Germany) 
Knockout™ DMEM/F-12 (1X) Gibco®, Life Technologies GmbH, Darmstadt (Germany) 
mTeSR™1 StemCell™ Technologies, Grenoble (France) 
TeSR-E8 StemCell™ Technologies, Grenoble (France) 
REBM   (Basal medium+ Bullet kit) Lonza (Switzerland)  
RKCM RNL Bio (Korea) 
StemDiff APEL StemCell™ Technologies, Grenoble (France) 
OptiMEM Life Technologies GmbH, Darmstadt (Germany) 
  
KITS MANUFACTURER/SUPPLIER 
Rneasy®Micro/Mini Kit (Qiagen) Qiagen®, Hilden (Germany) 
CrimsonTaqTMMasterMixKit New England Biolabs (USA) 
SuperScript® III First-Strand Synthesis 
System 
Invitrogen™, Life Technologies GmbH, Darmstadt 
(Germany) 




β -2-Mercaptoethanol Invitrogen™, Life Technologies GmbH, Darmstadt 
(Germany) 
Glutamax Invitrogen™, Life Technologies GmbH, Darmstadt 
(Germany) 
Hydrocortisone Sigma-Aldrich, St. Gallen (Switzerland) 
Insulin-Transferrin-Selenium Sigma Aldrich, St. Gallen (Switzerland) 
Fetal calf serum Biochrom AG, Berlin (Germany) 
Pen Strep 10000 Units/ml  Gibco®, Life Technologies GmbH, Darmstadt (Germany) 
ActivinA PeproTech, Hamburg (Germany) 
BIO InSolution™ GSK-3 Inhibitor IX , Calbiochem, Merck 
KGaA, Darmstadt (Germany) 
rhBMP4 PeproTech, Hamburg (Germany) 
rhBMP7 PeproTech, Hamburg (Germany) 
rhbFGF/FGF2 PeproTech, Hamburg (Germany) 
rh GDNF PeproTech, Hamburg (Germany) 
rhHGF PeproTech, Hamburg (Germany) 
Retinoic Acid Stemgent (USA) 
Y27632 Wako Chemicals Inc.( USA) 
  
SOFTWARE MANUFACTURER/SUPPLIER 
Columbus Image Data System Perkin Elmer, Waltham (USA) 
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FlowJo Version 8.8.2 Tree Star, Inc., Ashland (USA) 
GraphPad Prism GraphPad Software, California (USA) 
QCapture QImaging (Canada) 




3.1. Culture and maintenance of human pluripotent stem cells (PSCs). 
3.1.1. hPSC culture conditions 
The hPSC were tested in various conditions to find the best suited culture media for the colonies 
to remain undifferentiated and healthy. Broadly, the conditions can be classified as feeder cell 
co-culture and feeder free culture (Figure 10). 
 
Figure 10: Different conditions of iPSC culture 
3.1.2. Preparation of feeder cell cultures 
Human embryonic and induced pluritpotent stem cells have been classically cultivated on 
feeder layers of mouse embryonic fibroblasts (MEF) or human foreskin fibroblasts (HFF). MEF 
(CF-1 strain) were cultured in Dulbecco’s Modified Eagle Medium (DMEM) containing 10% 
fetal calf serum (FCS), 1% glutamax, 1% Non-Essential Amino Acids (NEAA), 1% 
penicillin/streptomycin and HFF were cultured in Iscove's Modified Dulbecco's Medium 
(IMDM) containing 10% FCS and 1% penicillin/streptomycin. Stocks of both the cell types 
were prepared for future cultivation of pluripotent stem cells. MEFs/HFFs were thawed and 
plated and cultured for several days. During these days cell numbers increased while MEFs still 
had growth potential. After 3 expansions (passages), the cells were trypsinized and the cell 
suspension was exposed to gamma irradiation (30 Gray) to inactivate the fibroblasts, impairing 
mitosis and avoiding further growth. Inactivated MEFs were washed and frozen in a solution 
containing 40% DMEM basic medium, 50% FBS, 10% DMSO and stored in liquid nitrogen. 
When hPSCs need to be cultured, feeder cell plates are prepared by thawing MEFs/HFFs the 
day before on gelatin coated dishes and incubated in iPSC medium for acclimatisation. 
























Conditioned media was harvested from confluent monolayers of γ-irradiated MEF and HFF in 
a T175 flask cell culture system (MEF-CM and HFF-CM respectively). Irradiated fibroblasts 
were plated in MEF medium and from the following day for a week, the cells were provided 
human iPSC medium (30 ml). Every day, the conditioned media was collected, filtered to 
remove cellular debris, and frozen at -20 ̊C. 
3.1.4. Subcultivation of hPSCs on feeders 
In feeder cell co-cultures the used iPSC medium was composed of Knockout DMEM/F12 and 
Knockout Serum Replacer (KSR), NEAA, glutamax, β-Mercaptoethanol, bFGF and 
gentamycin. During thawing of the iPSC master culture, ROCK inhibitor- Y27632 was added 
to prevent apoptotic loss of cells.  
Table 6: Standard iPSC medium 
COMPONENT CONCENTRATION FOR 500 ML: 
Knockout DMEM/F12  388ml 
Nonessential amino acids (100x) 0,1 mM 5 ml 
GlutaMax –I, Solution (100x), 200 mM  5 ml 
Gentamycin 50 µg/ ml Med. 2 ml (of 12,5 mg/ ml) 
Knockout Serum Replacer (KSR) 20% 100 ml 
Sterile filtration 0,22 µm   
ß Mercaptoethanol 0,1 mM 1 ml 
bFGF 10 ng/ ml 500 µl (of 10 µg/ ml) 
ROCK Inhibitor (Thawing medium only) 5mM 1ml 
 
Two kinds of subcultivation techniques were utilized to expand iPSC cultures - mechanical and 
enzymatic. Human iPSC colonies cultivated on feeder layers were preferentially passaged 
mechanically using a Stem Cell Cutting Tool. Briefly, the cutting tool was used to mark the 
borders of the undifferentiated colony with the sharp edge and gently loosened with the blunt 
side to let them float. The floating colonies were collected using the pipetting function of the 
tool and transferred onto new feeder plates in a desired ratio. Enzymatic passaging was 
performed using Dispase or Collagenase IV. The spent medium was aspirated and washed with 
KO-DMEM/F12. The enzyme collagenase IV was added and incubated for 7-10 minutes until 
the edges of the colonies seemed separate; at this point the enzyme was removed. The cells 
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were rinsed with KO-DMEM/F12 and the colonies were collected, centrifuged and replated on 
fresh feeders at the desired ratio. 
3.1.5. Feeder free culture of iPSC 
To culture the iPSC in feeder free conditions mTeSR-1 medium was tested other than MEF-
CM and HFF-CM. mTeSR-1 is a complete serum-free, defined formulation designed for the 
feeder independent maintenance and expansion of human embryonic stem cells (hESCs) in the 
undifferentiated state (Ludwig et al., 2006). Complete mTeSR-1 medium (Basal Medium + 5X 
Supplement) contains recombinant human basic fibroblast growth factor (rh bFGF) and 
recombinant human transforming growth factor β (rh TGFβ). In the feeder free culture system, 
cells were cultured in Matrigel coated flasks. Enzymatic passaging was performed using dispase 
as in the procedure mentioned before. This enzyme allowed cells to remain in clumps, which 
has been shown to be essential for hPSC propagation. After cells have been incubated for 7 min 
at 37 °C with dispase, the enzyme is removed and cell clumps were washed and detached from 
the plate using a scraper and suspended in 2 mL medium to wash the dispase. Cells were 
centrifugated at 300 x g for 5 minutes. The supernatant was removed and cell pellet was was 
re-suspended and plated onto a new culture dish. 
The feeder-free culture conditions were eventually shifted to TeSR-E8 medium (Stemcell 
Technologies) on Geltrex (Life technologies) coated dishes following the determination of 
essential eight components of pluripotent stem cell culture. Cultures were fed daily and 
passaged every 4–6 days with gentle cell dissociation reagent (Stemcell technologies) for 5 min 
at 37°C and then manually detached from the dish using a cell scraper. The resulting clumps of 
cells were plated in a ratio of 1:6. 
3.1.6. Morphological distinction between hPSCs and differentiated cells 
Due to high nuclear cytoplasmic ratio, the hESC colonies form ordered, flat, tight colonies with 
sharp borders, with low light scattering properties while the differentiating colonies are 
apparently disordered or irregular with uneven edges or transparent centers and exhibit high 
light-scattering property. Also the differentiated cells look bigger than undifferentiated cells 
due to the reduced nuclear-cytoplasmic ratio. 
3.1.7. Single cell preparation of hPSCs 
Although regular expansion of PSC colonies was performed as mentioned above, when cells 
were required in a standard fashion for experiments, they were preferred as single cells in order 
to be quantified for seeding. For this procedure, the enzyme mixture Accutase was added to the 
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cells and incubated at 37°C for 7 minutes. This enzyme mixture cannot be neutralized and 
therefore was diluted with twice the volume of medium. The cells suspended in this enzyme-
medium mixture are centrifuged at 300xg for 5min. The supernatant was discarded and the 
pellet is re-suspended in medium containing ROCK-inhibitor. Cells are seeded at a required 
density and maintained in medium containing ROCK-inhibitor for 24 hours after which it was 
replaced by the test medium. 
3.1.8. Cryopreservation of hPSCs 
The procedure for freezing human PSCs is identical to that of passaging these cells till the final 
step of re-suspending the cell clumps. Shortly, colonies were incubated with dispase, washed 
with KO-DMEM/F12 and gently lifted out with a cell scraper. Then the clumps were collected, 
centrifuged for sedimentation and re-suspended gently in pre-cooled freezing medium (60% 
FBS, 20% DMSO and 20% culture medium). Usually cells clumps collected from one well of 
a 6-well plate were suspended in 1ml of freezing media and accommodated in a 1 ml cryovial, 
which was placed in a freezing container (Nalgene) and stored at -80°C overnight were 
transfered to liquid nitrogen for long-term storage the following day. 
* To obtain higher efficiency during thawing, cells clumps for freezing should be slightly larger 
than those used for splitting. 
3.1.9. List of PSCs utilized. 
Table 7: Human PSCs utilized in this study 
CELL LINE SOURCE VECTOR FACTORS REFERENCE 





Lentivirus Oct4, Sox2,Nanog, 
Lin28 
Yu Junying et al. 
2007 
BCRTi004 Urinary cells Sendai 
virus 
Oct4, Sox2, Klf4, 
cMyc 
Rossbach et al. 
2016a 
BCRTi005 Urinary cells Sendai 
virus 
Oct4, Sox2, Klf4, 
cMyc 







3.2. Stem cell Differentiation 
3.2.1. Media 
The basal medium used for differentiation during screening experiments was prepared in the 
lab by adding B.S.A (1.8%) and NEAA (0.1mM) to DMEM/F12 with high glucose containing 
Glutamax and Sodium Pyruvate. On obtaining 4 candidate growth factor combinations, the 
basal medium was switched to xeno-free, serum free defined APEL medium (Ng et al., 2008). 
3.2.2. Extracellular matrices 
Tissue culture and tissue multiwell plates used for iPSC cultivation where pre-coated with 
GeltrexTM Matrix 1:30 in Knockout DMEM for one hour at RT or at 4 C, overnight. Other 
matrices used for differentiation include Collagen A (diluted 1:1) and rhLaminin521 (10µg/ml) 
both dissolved in PBS containing Calcium and Magnesium. 
 
3.2.3. Growth factors 
Table 8: Concentration of growth factors used 





Meso factors : A ActivinA (2ng/µl Stock) 10ng/ml 50µl 
 
B4 BMP4 (2ng/µl Stock) 30ng/ml 150µl 
 
RA Retinoic Acid 1µM 1µl 
 
BIO BIO 1µM 1µl 
Nephro factors : B7 BMP7 (2ng/µl Stock) 15ng/ml 75µl 
 
F2 FGF2 (2.5ng/µl) 10ng/ml 40µl 
 
G GDNF (5ng/µl) 150ng/ml 300µl 
Podo factor HGF HGF(10ng/µl) 50ng/ml 50µl 
 
 
3.2.4. Optimal protocol 
For differentiation experiments, a single cell suspension was prepared by treating a confluent 
PSC culture with Accutase (Life Technologies) and seeding in stem cell culture medium 
containing 10µM Y27632(Wako) at a density of 10,000cells/cm2 for 24 hours. The seeded cells 
are maintained in stem cell culture medium until attainment of 75% confluency when induction 
factors are applied for specified time periods. Differentiation media used in all stages was 
prepared using STEMdiff APEL Medium (Stemcell technologies) as a base medium, to which 
growth factors and inhibitors were added as required. During Stage I, 10ng/ml Activin A 
(Peprotech), 30ng/ml rh-bone morphogenetic protein 4 (BMP-4; Peprotech) with either 10 µM 
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all-trans-retinoic acid (RA; Sigma-Aldrich) or 10 ng/ml basic fibroblast growth factor (bFGF, 
Peprotech) or 15ng/ml rh-BMP7 (Peprotech) or 3µM (2ʹZ, 3ʹE)-6-Bromoindirubin-3ʹ-oxime 
(BIO; Sigma-Aldrich) was added to APEL base. Stage II media were composed of 150ng/ml 
Glial-Derived Neurtrophic Factor (GDNF, Peprotech) or alternatively a combination of 
15ng/ml BMP7 and 10ng/ml bFGF. During the course of differentiation, medium was 
replenished every 48 hours. 
For the terminal differentiation, cells obtained at the end of day 8 were replated on Laminin521 
(BioLamina) and treated with medium containing 50ng/ml rh-Hepatocyte Growth Factor (HGF; 
Peprotech) for podocyte differentiation or alternatively Renal Epithelial Growth Medium 
(REGM; Lonza) for tubular epithelial differentiation and in a medium containing 15ng/ml 
BMP7 and 10ng/ml FGF2 for mesangial cells. 
 
3.3. Characterization of PSC-derived cells. 
 
3.3.1. Gene expression analysis 
Relative gene expression analysis was performed by semi-qualitative reverse transcriptase PCR 
(RT-PCR), quantitative real-time PCR (qPCR) and RNA-Seq analysis. 
 
3.3.1.1. RNA ISOLATION:  
RNA isolation from cell lysates was performed using the RNeasy® Mini Kit (Qiagen) 
following the manufacturer’s instructions, including the optional step of DNase I treatment of 
the samples on column to get rid of trace amounts of genomic DNA. This technology combines 
the selective binding properties of a silica-based membrane with centrifugation which enables 
the capture and purification of up to 100 μg of RNA longer than 200 bases by binding to the 
silica membrane in a column. The procedure provides enrichment for mRNA since most RNAs 
<200 nucleotides (such as 5.8SrRNA, 5S rRNA, and tRNAs, which together comprise 15–20% 
of total RNA) are selectively excluded. 
First, the cells were briefly rinsed with pre-warmed PBS (37°C) and RLT lysis buffer (highly 
denaturing guanidine-thiocyanate–containing buffer) to which β-mercaptoethanol was added at 
the rate of 10 μl per 1 ml RLT Buffer prior to use. 600 μl Then the cells were scraped out using 
a cell scraper and collected in a 1 ml microcentrifuge tube, followed by thorough vortexing for 
1 minute to ensure proper cell lysis. Then the lysates were transferred to RNeasy-columns and 
further RNA isolation was carried out according to the manufacturer’s instructions. RNA was 
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eluted into RNAsefree tubes using 22 μl of RNAse-free sterile water, out of which 2 μl was 
used for quality check by agarose gel electrophoresis and quantification.  
The quantity and quality of RNA and cRNA was determined using a spectrophotometer 
(NanoDropTechnologies, Wilmington, DE, USA). This technology combines fibre optics and 
surface tension to measure small amounts of sample. 1μl of sample was loaded onto the optical 
pedestal of the NanoDrop and its arm is closed. The sample is held by surface tension as a 
column during the measurement. If the concentration exceeded saturation limits, the samples 
were diluted by adding RNAse-free sterile water. 
 
3.3.1.2. RT-PCR  
Reverse transcription was performed using the SuperScript® III First-Strand Synthesis System.  
Whole volume of isolated RNA was used to generate cDNA. 50μM OligodT and 10mM dNTPs 
were added to the RNA samples and made up with sterile distilled H2O to a volume of 13 μl. 
The samples were incubated at 65°C for 5 minutes and then placed on ice for 1 minute. A 
mixture of 4μl 10x RT buffer, 1μl 0,1M DTT, 1μl RNaseOut and 1μl Superscript III RT were 
added to the samples, making it a 20μl reaction volume. The reverse transcription reaction was 
performed at 50°C for 1h and inactivated at 70°C for 15 minutes. Generated cDNA was 
measured with the NanoDropTM Spectrophotometer at 260nm and stored at -20°C for further 
use. 
 
Specific genes were amplified from the obtained cDNA by the application of certain primers 
listed in Table 4. The components of the CrimsonTaq Master Mix Kit (New England Biolabs), 
were mixed with the yielded cDNA as depicted in Table 8. For each primer an additional 
negative control was applied (without cDNA). GAPDH (Housekeeping gene) was used as the 
positive control.  
 
Gels of 1-3% were prepared by mixing agarose (Life Technologies, Paisley, Scotland) in 1x 
TAE buffer. 1μl of GelRed was added directly to the gel and mixed before solidifying. To assign 
the length of the amplicons the GeneRulerTM 1kb DNA ladder (Fermentas, St. Leon-Rot, 
Germany) was used. Gels were run in an electrophoresis chamber with 90V for 30 to 60min. 





Table 9: PCR amplification Mix 
Component Concentration 1x Sample 
5X Reaction buffer 1X 5µl 
cDNA Template 1µg n µl 
dNTP Mix (10mM) 200µM 0.5µl 
Forward Primer (10µmol) 0.2µM 0.5µl 
Reverse Primer (10µmol) 0.2µM 0.5µl 
TopTaq DNA Polymerase 1.25 units 0,125µl 
RNase free H2O  Fill up to 25µl 
 
Table 10: Thermocycling conditions. 
Step  Temperature Time  Cycles 
Initial melting 95° C 5 min  
Melting 95° C 30 sec 30 
Primer annealing n° C 30 sec 
Elongation 72° C 30 sec 
Final elongation 72° C 10 min  
Cooling 4°C ∞  
 
3.3.1.3. RNA-Seq library preparation and NGS 
For Illumina HiSeq 2000 RNA sequencing, RNA-Seq library preparation and NGS: cDNA 
libraries from poly-A-tail enriched RNA were prepared from 3 biological replicates for each 
timepoint, using TruSeq mRNA sample prep kit v.2 (Illumina). Sequence alignment and RNA-
Seq analysis: Bcl to fastq conversion was performed using Illumina software (Illumina). Fastq 
files were aligned to build 19 of the human genome provided by the Genome Reference 
Consortium (GRCh19). Transcript alignment was performed using TopHat. Analysis (Trapnell 
et al., 2009) of differential expression and transcript abundance was performed using Cuffdiff 
(Trapnell et al., 2010) from the Cufflinks analysis package (version 2.1.1). The transcript levels 
(expressed as Fragments per Kilobase of transcript per Million mapped reads; FPKM) of the 
samples were used to plot heatmaps based on Pearson correlation, using R (R Development 
Core Team (2011)) (version 3.1 or greater).The data (significantly impacted pathways, 
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biological processes, molecular interactions, miRNAs, SNPs, etc.) were also analyzed using 
Advaita Bio’s iPathwayGuide(Draghici et al., 2007). 
RNA-Seq data for 22 samples has been deposited at the GEO database with the accession 
number GSE75711. 
 







D14-1 D14-1 Day 14 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 
acid, 4 days of GDNF and 6 days of HGF 
D14-3 D14-3 Day 14 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 
acid, 4 days of GDNF and 6 days of HGF 
D2-1 D2-1 Day 2 of nephron cell 
induction 
IPS cells exposed to 2 days of ActivinA,BMP4,Retinoic 
acid 
D2-2 D2-2 Day 2 of nephron cell 
induction 
IPS cells exposed to 2 days of ActivinA,BMP4,Retinoic 
acid 
D2-3 D2-3 Day 2 of nephron cell 
induction 
IPS cells exposed to 2 days of ActivinA,BMP4,Retinoic 
acid 
D4-1 D4-1 Day 4 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 
acid 
D4-2 D4-2 Day 4 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 
acid 
D4-3 D4-3 Day 4 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 
acid 
D6-1 D6-1 Day 6 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 
acid and 2 days of GDNF 
D6-2 D6-2 Day 6 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 
acid and 2 days of GDNF 
D6-3 D6-3 Day 6 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 
acid and 2 days of GDNF 
D8-1 D8-1 Day 8 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 
acid and 4 days of GDNF 
D8-2 D8-2 Day 8 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 
acid and 4 days of GDNF 
D8-3 D8-3 Day 8 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 
acid and 4 days of GDNF 
H1_d8-1 H1_d8-
1 
Day 8 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 
acid and 4 days of GDNF 
H1_d8-2 H1_d8-
2 
Day 8 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 












undiff-3 NA no treatment 
T315918; 
U1-Strati-I 
D8-4 Day 8 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 
acid and 4 days of GDNF 
T316019; 
U2-Strati-II 
D8-5 Day 8 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 
acid and 4 days of GDNF 
T316120; 
U3-Strati-V 
D8-6 Day 8 of nephron cell 
induction 
IPS cells exposed to 4 days of ActivinA,BMP4,Retinoic 




3.3.2. Detection of proteins by Immunocytochemisty 
 
3.3.2.1. Immunofluorescence staining of cells and tissues  
For immunofluorescence staining, cultured cells were washed with phosphate-buffered saline 
(PBS) and fixed with BD Cytofix for 10 min. If necessary, cells were then permeabilized with 
BD Perm/Wash for 15 min. Cells were washed twice with PBS and blocked with 10% 
secondary antibody host serum in washing buffer for 30 min at 37°C. Cells were incubated 
overnight at 4°C with primary antibodies (Table 3) diluted in Perm/Wash buffer. Cells were 
then washed three times (5 min each) and incubated with fluorescence-labeled secondary 
antibodies in washing buffer at room temperature for an hour and rinsed three times (5 min 
each) with PBS. For negative controls, only the secondary antibody was used (results not 
shown). The fluorescent dye 4′, 6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich, D-8417) 
was used for staining nuclei. Images were obtained using the Operetta High content imaging 
system (Perkin Elmer) and analysed using Columbus (Perkin Elmer) software. 
 
3.3.2.2. Flow cytometry  
Cells were detached to a single-cell suspension using trypsin and stained for LIVE/DEAD™ 
Fixable Blue (ThermoFisher Scientific) for 30 min. For labeling of intracellular antigens, cells 
were permeabilized by incubation with Phosflow Perm Buffer II (BD Biosciences) for 15 min. 
Cells were incubated with primary antibody (Table 3) diluted in ice-cold buffer (1% (vol/vol) 
Fetal calf serum in PBS) for 30min. Cells were incubated with appropriate secondary antibodies 
(donkey anti-mouse IgG Alexa 647 or donkey anti-donkey IgG Alexa 488) if they were not 
conjugated with a fluorophore. Cell labeling was measured using a LSR Fortessa cell analyzer 
(BD Biosciences) and analyzed with FlowJo software (FLOWJO LLC). 
 
3.3.3. Assays demonstrating potency, tubulogenic and angiogenic capacities of 
cells. 
3.3.3.1. Pellet culture assay  
The pellet culture was adapted from Takasato 2014. PSC-derived cells were harvested and 
dissociated into single cells using Accutase (ThermoFisher Scientific) at day 8-9 of the 
differentiation. Around 3-5x10 5 cells were spun down at ×400g for 5 min to form a pellet and 
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then placed onto a transwell filter membrane (0.4µm polyester, Greiner bio-one) on the culture 
media of 10% FCS/DMEM for 4 days. 
 
3.3.3.2. Mouse embryonic kidney re-aggregation assay  
The re-aggregation assay was performed as described by Xia et al. 2013. Briefly, embryonic 
kidneys from 12.5-dpc (days post coitum) mice were digested with Accutase for 10 minutes 
and washed with KCM containing 10% FCS and placed in a low-binding eppendorf vial 
together with 3x105 day 8 hiPSC-derived renal cells; the tubes were centrifuged at 190g for 5 
min. The supernatant was removed, and the pellet was re-suspended in 120 μl KCM (MEM 
supplemented with 10% FBS) supplemented with 10 μM ROCK inhibitor (Sigma). The cells 
were pelleted in the same PCR tube at 190g, 4 °C for 5 min. The PCR tube was placed upright 
in the incubator for 12 h. The aggregates were then transferred onto transwell filters (0.4µm 
polyester, Greiner bio-one) with KCM in the lower chamber. Following 4 days of culture, the 
whole aggregates from both the pellet culture and embryonic re-aggregation were fixed and 






4.1. Development of a protocol for differentiation of pluripotent stem cells towards the 
renal lineage. 
The strategy- Screening of growth factors in a chemically defined medium initially involved 
two broad steps, the first being mesodermal induction and the second specifying cells to the 
nephric lineage. hPSCs have been used to generate several mesodermal lineages in vitro, 
including heart, bone and cartilage and hematopoietic system. This information indicates that 
steering a PSC to the mesodermal lineage through the primitive streak (PS) is feasible, although 
the path to intermediate mesoderm and further to urogenital systems has yet to be uncovered. 
 
4.1.1.  Literature mining for potential modifiers of stem cell fate. 
The balance of BMP and Activin/Nodal signaling with canonical Wnt signaling has been known 
to specify the cell fate of hPSC-derived-nascent PS into mesoderm or endoderm progenitors 
(Sumi et al., 2008). FGF2 can switch the fate of BMP4-induced human PSC, to mesendoderm, 
which is characterized by the uniform expression of T (Brachyury) and other primitive streak 
markers, by acting through the MEK-ERK pathway (Yu et al., 2011). Wnt3 and beta-catenin 
play an important role in vertebrate axis formation (Liu 1999), and when applied in conjugation 
with activinA, this combination induced hPSCs to form T+ mesendoderm cells (Lam et al., 
2014). Also, RA is a morphogen specifying the anterio-posterior axis, a caudalizing agent that 
influences HOX genes during embryonic development (Durston et al., 1989; Mavilio et al., 
1988). A combination of activinA and RA induces pronephric markers in vitro in Xenopus and 
mESCs (Kim and Dressler, 2005; Osafune et al., 2002). In addition, it is known that BMP7-
deficient mice die shortly after birth due to impaired kidney development, since BMP7 affects 
the expression of key signaling components in nephrogenesis, such as Pax-2 and Wnt-4 between 
12.5 and 14.5 days post-coitum (dpc) (Luo 1995, Dudley et al., 1995; Torban et al., 2006). 
Considering this evidence, we used activinA and BMP4 (AB4) as a constant base to initiate 
nephrogenesis in combination with either FGF2 (F2) or BMP7 (B7) or retinoic acid (RA) or the 
Wnt agonist BIO. Human PSC were exposed to these factor combinations for 4 days (Fig.11).  
 
To spur nephrogenesis further in vitro, we attempted to derive early stages of renal cell 
specification by supporting mesenchyme growth and branching morphogenesis. MM-derived 
GDNF was shown to promote UB differentiation and branching, and provide a positive 
feedback to MM cells (Majumdar et al., 2003; Sainio et al., 1997). Dudley et al. have 
demonstrated that BMP7 signaling can prevent apoptosis in explants of mouse MM and in 
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conjunction with FGF2; BMP7 promotes growth and maintains competence of the mesenchyme 
in vitro (Dudley et al., 1995, 1999). A biphasic role for BMP7 has been proposed where BMP7 
elicits MAPK-dependent cap mesenchyme (CM) proliferation and regulates cell survival and 
interstitial progenitor phenotype via SMAD signaling(Oxburgh et al., 2011). Therefore, in a 
second step, we selected GDNF and BMP7-FGF2 to elucidate their effect on differentiation of 
AB4RA, AB4F2, AB4BIO and AB4B7 induced cells for four further days (Fig.11). 
 
 
Figure 11: Strategy of the screen and combination of growth factors corresponding to the developmental 
milestones described in literature for renal linage specification. FGF-Fibroblast growth factor, BIO- (2ʹZ, 3ʹE)-
6-bromoindirubin-3ʹ-oxime, RA- Retinoic Acid, BMP- Bone morphogenetic protein, GDNF- Glial-derived 
Neurotrophic Factor. 
4.1.2. Gene expression pre-screen identifies 4 promising growth-factor 
combinations to induce renal lineage. 
The resulting 15 combinations were subjected to an initial screen based on RT-PCR of samples 
at the end of 8 days of treatment. Renal progenitors have transcription factor signatures that 
allow their identification, ranging from IM to MM and ND. Based on the loss-of-function 
phenotypes and expression patterns in various mutants, the early patterning genes appear to fall 
into two groups: 1) genes that specify the intermediate mesoderm along the mediolateral axis, 
such as Lim1, Odd1, Pax2/8; and 2) genes that specify the intermediate mesoderm along the 
anterior-posterior axis, such as the Hox11 group, Eya1, Six, and Wt1(Dressler, 2006). 
Therefore, we chose SIX2, LHX1, OSR1, PAX2, EYA1 and WT1 (S.L.O.P.E.W) as candidates 
to check the successful steering of PSCs to the renal lineage. (A description of the roles played 
by these genes and the phenotype caused by their loss of function can be found in the appendix). 
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An evaluation of the expression profile generated by RT-PCR allowed the shortlisting of 
combinations AB4B7, AB4BIO-B7F2, AB4F2-G and AB4RA-G, as they possessed a 
minimum S.L.O.P.E.W score – 4/6 (Fig.12).  
 
Table 12: Expression of developmentally significant transcription factors during differentiation evaluated 




Figure 12: The 4 selected growth factor combinations with respect to approximate developmental stage and 
time. 
 
4.1.3. AB4RA-G treatment for 8 days is highly efficient in generating the renal 
progenitor population. 
Further screening was performed by means of high-content screening of the transcription 
factors important in the developmental cascade, as detected by immunofluorescence. The first 
time point, day 4, was chosen to check for the induction of mesoderm and specification into 
intermediate mesoderm. The indication of S.L.O.P.E.W signature by RT-PCR experiments led 
to the selection of day 8 as a second time point. The assay was performed to visualize the 
disappearance of OCT4, marking the loss of pluripotency and the subsequent appearance of T+ 
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cells representing a mesendodermal commitment of stem cells. SOX17 was used to identify 
nascent definitive endoderm cells, a population of a contaminating nature as we aim to achieve 
maximum induction of mesoderm. Also, SIX2, LHX1, OSR1, PAX2, WT1 and CDH1 were 
investigated. Evaluation of the extent of differentiation by day 4 shows the co-expression of 
OCT4 and T in conditions AB4B7, AB4BIO and AB4F2 while AB4RA treated cells lost OCT4 
and express T in isolation (Fig.13). In line with the observation by Keong Teo et al. that OCT4 
and BRACHYURY are still co-expressed in hESCs grown for 24 h in endoderm-promoting 
conditions, remarkably high numbers of SOX17+ cells are seen in AB4BIO and AB4F2 
samples (Teo et al., 2011). Although AB4B7 did not show induction of SOX17, as previously 
shown in RT-PCR studies, this combination was rather inefficient in inducing PAX2, OSR1 or 
SIX2 after 4 days of treatment.  AB4BIO and AB4F2 triggered higher intensities and lower 
number of PAX2 and SIX2 expressing cells while AB4RA on the other hand induced highest 
numbers of SIX2 and PAX2+ cells (Fig.13). None of the combinations seemed to display 
OSR1. The morphology of cells in all 4 combinations varied considerably; cells with expanded 
cytoplasm and large nuclei were seen in AB4B7, AB4BIO and AB4F2. The AB4RA cells were 
much smaller and numerous in comparison to the other 3 combinations, which can be attributed 
to the lower intensity of signal from the nuclei of these cells. 
Completion of the 8-day treatment resulted in total loss of OCT4 confirming differentiation of 
all PSCs. The sustained expression of T together with SOX17 in combinations AB4BIO-B7F2 
and AB4F2-G suggest the lack of developmental progression into the nephric lineage although 
a considerable number of OSR1, PAX2 and SIX2 + cells were observed (Fig.14). AB4B7 
improved its performance in terms of SIX2+ and OSR1+ cells but was contaminated by the 
presence of SOX17+ cells. AB4RA showed some remnant populations of T+ cells, the highest 





Figure 13: Screening of the optimal growth factor combination for renal progenitor generation after 4 days. 
The number of nuclei expressing the transcription factors OCT4, T, SIX2, SOX17, PAX2 and OSR1 out of 1000 
nuclei in every combination were quantified using high content image analysis as shown in the 
accompanying graphs portraying count (each cell = 1 count) versus intensity of fluorescence of the nuclei.  

























Figure 14: Screening of the optimal growth factor combination for renal progenitor generation after 8 days. 
The number of nuclei expressing the transcription factors OCT4, T, SIX2, SOX17, PAX2 and OSR1 out of 1000 
nuclei in every combination were quantified using high content image analysis as shown in the 
accompanying graphs portraying count (each cell = 1 count) versus intensity of fluorescence of the nuclei. 





































Testing the best performer AB4RA-G on several PSC lines indicated a high efficiency of renal 
progenitor generation within 8 days. While the cell line IMR90-iPS showed 60% efficiency, 
two urinary cell-derived induced PSC-lines generated in our lab: BCRTi004 and BCRTi005 
attained 75-80% efficiency in terms of SIX2 expression (Fig.15). The occurrence of LHX1 in 
a majority of the cells at this stage in conjunction with PAX2 corresponds to the manifestation 
of nephric duct as well as representative of RV cells. Moreover, association of LHX1 cells and 
CDH16 demonstrates the synchronous development of the ureteric epithelium(Karavanov et 
al., 1998; Shen et al., 2005). Therefore, AB4RA-G was verified to be the optimal protocol for 
deriving major renal progenitor populations including MM, ND and RV. 
 
Figure 15: Efficiency of generation of renal progenitors. Flow cytometric analysis of day-8 cells generated shows 
SIX2+/PAX2+ cells representative of MM. LHX1+/PAX2+ cells representative of pre-tubular aggregate and together with 
CDH16 indicative of ND cells. Day 8 cells were generated from the human pluripotent stem cell lines IMR90-4-iPS and 
lab-derived iPSC lines BCRTi004 and BCRTi005. 
4.1.3.1. Morphological characteristics 
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The process of differentiation was accompanied by marked morphological changes of the cells. 
In AB4RA for 2 days, hPSCs began losing their compact structure and spread out throughout 
the culture surface accompanied by cell proliferation and considerable amount of cell death. 
Following two further days of AB4RA, the differentiating cells began forming dome-like 
structures in culture (Fig.16). Removal of AB4RA and addition of GDNF for the next 4 days 
lead to a loss of dome-like structure and cessation of massive cell death. A heterogeneous cell 
mass characterized by epithelial islands surrounded by mesenchymal cells was observed by the 
eighth day of differentiation (Fig.16). A starting culture of hPSCs (~ 800,000 cells) yields 
around 4 million cells (up to 5-fold increase). 
 
Figure 16: Morphological characteristics of AB4RA-G. Pluripotent stem cells colonies (D0) exposed to AB4RA form 
confluent cultures exhibiting dome formation (arrowhead) by D4. GDNF treatment is followed by rapid proliferation 





4.2. Dissecting the molecular signatures of renal progenitors derived from hPSC. 
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4.2.1. AB4RA effectively breaks pluripotency coaxing the appearance of 
mesendodermal cells in 2 days. 
iPS cells are generated by reprogramming somatic cells back to pluripotent state with defined 
reprogramming factors, OCT4, SOX2, KLF4 and C-MYC (also known as Yamanaka factors). 
These transcription factors and their downstream target genes coordinately promote self-renewal 
and pluripotency hence the first step of differentiation involves the disruption of this state. When 
PSCs are treated with the activinA-BMP4-RA combination for 48 hours, OCT4, NANOG and 
cMYC are down-regulated, promoting germ layer formation (Fig. 17). KLF-4 on the other hand 
was up-regulated, concurring with evidence from Xenopus suggesting the involvement of Klf-4 
as a competence factor in early embryonic cells to be responsive to inducing signals for germ-
layer differentiation and body axis patterning (Cao et al., 2012).  
An increase in the expression of ACVR1 indicates a response to activinA provided in the 
induction medium. Also, notable changes are the upregulation of BMP4 and WNT3 that help 
in defining mesodermal identity. While BMP4 was provided in the induction medium and 
activation of its downstream SMADs or feed forward loop is obvious, the WNT and FGF 
pathway have likely been switched on by reciprocal signaling of cells creating several different 
cell populations (Fig.17 bar graph). Existence of all three germ layers can be marked by the 
appearance of several early lineage signatures. For example, Dlx5 is one of the earliest known 
markers for the most rostral ectoderm, before the formation of an overt neural plate(Yang et al., 
1998). Meis1 and Pax6 are involved in early neural and later pancreatic development (Cerdá-
Esteban and Spagnoli, 2014). 
 
Among the genes that are commonly accepted as mesoderm markers and key players in 
mesoderm specification and patterning, are those coding for the transcription factors, TWIST, 
SNAIL, GATA factors and Brachyury (T). GATA factors appear to play crucial roles in 
specifying mesendoderm in early development, later specifying endoderm, when mesoderm 
separates from endoderm(Technau and Scholz, 2003). The conserved chromosomal 
organization of Hox genes in clusters (four in vertebrates) is intimately linked to regulatory 




Figure 17: Signaling pathways regulating pluripotency of stem cells (KEGG: 04550): The pathway diagram is 
overlaid with the computed total perturbation of each gene. The highest negative perturbation is shown in dark blue, 







Embryonic mouse and chick studies suggested that mesoderm acquires positional information 
when emerging from the primitive streak (Tam and Beddington, 1987), and Frohman et al. 
proposed that differential Hox gene expression is established at that moment(Frohman et al., 
1990). Concurrent with literature, HOXA1, HOXA3 and HOXB1-2 are elevated after 48 hours 
of AB4RA treatment as seen in Table 13.  
Around 5-fold increase is seen in the case of TBX3 and HAND1 (Fig.17). TBX3 orchestrates 
a complex network of downstream effects within the T-box family members to direct 
pluripotent cells toward a mesendodermal fate (Weidgang et al., 2013). HAND1 belongs to the 
basic helix-loop-helix family of transcription factors and regulates cardiac 
morphogenesis(Riley et al., 1998). MEOX1 is important for somitic development (Mohamed 
et al., 2013) and PAX genes, also involved in organ development, are highly up-regulated 
(Table 13). Altogether, AB4RA treated PSCs were successfully coaxed to different lineages by 
2 days and began to show commitment towards specific parts of the mesoderm including LPM 
and PM together with HOX delineated anterio-posterior patterning. 
Table 13: Genes expressed differentially between Day 0 and Day 2 of AB4RA treatment. 
Gene symbol Gene name Log-FC P-value 
GATA3 GATA binding protein 3 6.920 1,89E-04 
GATA2 GATA binding protein 2 6.394 1,89E-04 
GATA6 GATA binding protein 6 4.691 1,89E-04 
GATA4 GATA binding protein 4 4.287 1,89E-04 
TWIST1 Twist family bhlh transcription factor 1 3.930 1,89E-04 
SNAI2 Snail family transcriptional repressor 2 2.455 1,89E-04 
SNAI1 Snail family transcriptional repressor 1 1.116 1,89E-04 
MEOX1 Mesenchyme homeobox 1 7.221 1,89E-04 
GSC Goosecoid homeobox 3.503 0.022 
PAX6 Paired box 6 4.725 1,89E-04 
PAX7 Paired box 7 3.116 3,61E-04 
HOXA1 Homeobox A1 10.000 1,89E-04 
HOXB1 Homeobox B1 8.612 0.008 
HOXA3 Homeobox A3 8.480 0.007 
HOXB2 Homeobox B2 6.896 1,89E-04 
HOXB3 Homeobox B3 4.867 8,33E-04 
 
 




4.2.2. Intermediate mesoderm cells pave the way for metanephric and ureteric cells 
by day 4. 
Two days of AB4RA exposure resulted in heterogenous PSC-derived progeny that represented a 
post-gastrulation embryo. According to the protocol, AB4RA treatment for sustained for two 
more days until day 4. It can be hypothesized that the developmental stage of the day 4 cells were 
specified to IM. 
 
Table 14: Genes expressed differentially between Day 2 and Day 4 of AB4RA treatment. 
 
Comparison of gene expression between day 2 and day 4 cells (Table 14) revealed an up-
regulation of OSR1 marking the IM accompanied by an increase in HOXB4 that marks the 
anterior boundary of IM in chick, regulated by RA signaling, causing LHX1 expression (James 
and Schultheiss, 2003; Preger-Ben Noon et al., 2009). Although the level of LHX1 was down-
regulated at day 4 (compared to day 2), this gene was active and was visualized in cells by 
immunofluorescence (Fig.19). No significant change was seen in the level of PAX2 between day 
2 and day 4. Also, the presence of LHX1+-PAX2+ cells (Fig.19) represents a nephric duct-like 
population. An approximately3-fold up-regulation of EYA1 in an OSR1+ context suggests a 
parallel development of nephrogenic mesenchyme, a stage similar to E9.0 in embryonic mice. 
Gene Symbol Gene Name Log FC P-value 
DCN Decorin 10.000 4,07E-04 
OSR1 Odd-skipped related transciption factor 1 6.453 4,07E-04 
HOXB4 Homeobox B4 4.873 4,07E-04 
HOXB7 Homeobox B7 3.863 4,07E-04 
EYA1 
EYA transcriptional coactivator and 
phosphatase 1 
2.906 4,07E-04 
AQP3 Aquaporin 3 2.044 4,07E-04 
KIF26B Kinesin family member 26B 1.901 4,07E-04 
NPNT Nephronectin 1.690 4,07E-04 
SIX2 SIX homeobox 2 1.631 4,07E-04 
LHX1 LIM homeobox 1 -1.783 4,07E-04 
OTX2 Orthodenticle homeobox 2 -2.072 4,07E-04 
RET Ret proto-oncogene -3.451 4,07E-04 
DAZL Deleted in azoospermia like -4.180 4,07E-04 
TDRG1 Testis development related 1 -4.242 7,60E-04 




Figure 19: Expression of IM, MM and UB related transcription factors in PSC-derived cells. Exposure to AB4RA-G 
induces expression of intermediate mesoderm and metanephric mesenchyme markers PAX2, LHX1, SIX2, and CITED1 
by day 4. (A-F). Expression of ß-CATENIN (G) and ureteric progenitor markers HOXB7 and GRHL2 (H, I) were seen by 
day 8. Scale bar = 50µm.  
 
The simultaneous up-regulation of HOXB7 (4.8 fold) and SIX2 (1.6 fold), however, points to 
the further development of ND to UB and nephrogenic mesenchyme to MM. This was also 
supported by the immuno-histochemical observation of these transcription factors (Fig. 19). In 
contrast to our hypothesis, the cells are more advanced in development than IM. Appearance of 
higher levels of DCN, NPNT and KIF26B illustrated the possible establishment of a niche for 
SIX2+ cells. The decrease in OTX2 and EGR3 suggests a reduction in neural development. 
Since IM cells are progenitors of kidney and gonads, the presence of TDRG1 and DAZL is 
unavoidable, but their down-regulation together with the emergence of MM and UB hints at the 
inability of the cell mixture to advance gonadal development. A morphological characteristic 
of AB4RA cultures at day 4 is the manifestation of domes due to fluid retention in the cell layer. 
RNA-Seq data indicate significant up-regulation of AQP3, SLC10A4 and SLC23A3 and 
several other solute career family members that actively transport electrolytes upon formation 
of a polarized epithelial layer.  
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Kinetics of IM and MM markers were investigated by immunofluorescence as the data from 
screening experiments with only 2 time points (day 4 and day 8) did not correlate with RNA-
seq. The transcription factor expression was quantified by high-content analysis of the image 
data. As seen at the RNA level, the markers initially appeared at day 2, rising steadily until day 
6 after which they were sustained till day 8 (SIX2) or died down by day 8 (PAX2, CITED1, 
LHX1). The efficiency of the protocol was measured in earlier experiments (Fig. 15) towards 
the regression of these markers and need to be reconsidered by their expression at day 4, which 
for IMR90-iPS-derived cells was ~85% (Fig.20). 
 
 
Figure 20: Quantification of developmental stage-specific transcription factors of AB4RA-G protocol..The 
number of nuclei positive for the desired markers was assessed by high-content image analysis every other day of 
differentiation. (n=3) 
The best recorded data of nephrogenesis in mammals is in the mouse model, making it a gold 
standard to assess the extent of renal differentiation. The top 198 differentially expressed genes 
(upregulated in day 4 versus day 2) were used to investigate the extent of enrichment of renal 
pathways by matching them to publicly available RNA-seq transcription profiles obtained from 
stage-specific embryonic kidney cells of the mouse (GUDMAP). Single cells were isolated 
based on different subsets in the nephrogenic zone. Significant correlations were obtained for 
3 major populations: MM, ureteric epithelium (UE) and stromal mesenchyme (SM). The genes 
most strongly representing this link as identified by Toppgene enrichment analysis (Chen et al., 
2009) are summarized in Fig. 21. While MM was majorly represented by transcription factors, 
the presence of genes KRT7 and EML5 are cytoskeletal and DCN, COL5A2, LUM are extra-
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cellular matrix organization, respectively for UE and SM, suggesting a more dynamic nature of 
the former and stabilized existence of the latter populations.  
 
 
Figure 21: Assessment of the association of genes highly regulated in PSC-derived cells and mouse embryonic 
kidney. Co-expression data illustrating the association of genes up-regulated in PSC-derived cells to different subsets 










4.2.3. GDNF activates UB, reciprocally inducing MM to form nephron epithelia 
The two important populations for the formation of the nephron and the collecting duct tree, 
which are the MM and UE respectively, are available by the end of day 4. The renal lineage is 
now specified and needs to be advanced to generate kidney cells. As per evidence from our 
screening to get maximal renal progenitors, following the exposure of PSC to AB4RA for 4 
days, they were treated with GDNF for the next four days. In mice, GDNF is generated by MM 
and promotes ureteric morphogenesis by priming the nephric duct for bud initiation and 
secretion of WNT11 (Appendix-Table). We have already seen the occurrence of 
LHX1+/PAX2+ cells accompanied by GATA3 expression in the previous result (Fig.19, 20 
and Table 9). These cells represent the responder population of GDNF secreted by MM cells. 
We hypothesized that strengthening UB activation will lead to formation of ureteric epithelia 
that naturally induce condensation of MM and its subsequent epithelialization. Changes in cell 
identity due to this treatment are dissected with the help of RNA-seq data of cells harvested at 
day4, day 6 and day 8.  
 
At day 4, cells show highest expression of SIX2-SIX1-SALL1 re-confirming the presence of 
MM (Fig.23). Sall1 is expressed in Six2-positive progenitors as well as differentiating nascent 
nephrons. Although in the mouse, the related transcriptional regulators Six1 and Six2 play non-
overlapping roles in nephron progenitors: transient Six1 activity prefigures, and is essential for, 
active nephrogenesis; by contrast, Six2 maintains later progenitor self-renewal from the onset 
of nephrogenesis. In humans, an auto/cross-regulatory loop drives continued SIX1 and SIX2 
expression during active nephrogenesis. (O’Brien et al., 2016). This population expresses 
KIF26B, produces NPNT (Table 9) and has the ability to secrete GDNF. The presence of RET 
(Fig.23) hints the readiness of the LHX-PAX2 expressing cells to receive the GDNF signal and 
activate UB formation indicated by the gradual appearance of CDH1 and SOX9 at day 6 that is 
prolonged till day 8. Expression of SOX9 can be found from the earliest stages of renal 
development within the ureteric tip, the ureter mesenchyme and in a segment-specific manner 
during nephrogenesis. SOX8/9 are required downstream of GDNF signaling for the activation 
of RET effector genes such as Sprouty1 and Etv5 (Appendix-Table). The presence of HOXB7 
was sustained and not significantly altered between Day 4 and Day8 as indicated by absolute 
FPKM values. Day 8 marks the highest expression of WNT11 and WNT9b demonstrating a 





The expression of several growth factors including FGF8, BMP7 and BMP2 are seen to increase 
until Day 8 along with the WNTs secreted by the UB population. The fate of SIX2+ MM cells 
to either maintain stemness and self-renewal or epithelial transition to form the renal vesicle is 
a decision based on the balance between BMP-FGF-WNT controlled ß-catenin (CTNNB1) 
gradient(Lindström et al., 2014). BMP7 activates CITED1 in SIX2+ cells, marker of the iMM. 
Concurrent with the sequence of embryonic events, we also observe a shift from CITED1+ cells 
at day 6 (CM) to the LEF1+, WNT4, FGF8 and HEY1 expressing population characteristic of 
the pre-tubular aggregate. (A description of the roles played by these genes and the phenotype 
caused by their loss of function can be found in the appendix, Appendix-Table) 
 
Surprisingly, the presumptive PTA also expressed several genes associated with stage I 
nephrons – the renal vesicle. Broadly, markers common to the proximal and distal RV-like 
stage, including JAG1, CCDC86, CDH6, WNT4, PAX8, NPY and CDH4 showed elevated 
expression at day 8. The distal expression of Notch (Dll1, Jag1), Bmp (Bmp2), and Wnt (Wnt4, 
Lef1, and Dkk1) pathway genes implies different cellular identity and activity along the 
proximal–distal axis ((Fig.23, 24) (Georgas et al., 2009; Kopan et al., 2007). Many of these 
genes are critical for specification of specific nephron segments. WT1 was also expressed at 
day 8 marking proximal RV. LHX1, POU3F3 (Brn1), GREB1 and DLL1 were expressed at 
day 2 with a higher expression at day 4 already. Genes such as Lhx1 and Pou3f3 occupy distal 
RV domains, whereas Wt1 expression becomes restricted to proximal regions. Notch signaling, 
predominantly Notch2, is critical for the elaboration of proximal nephron fates (podocytes and 
proximal tubules) whereas Lhx1 regulates patterning of distal tubular structures. Lhx1 is 
upstream of Notch2, which in turn regulates the onset of expression of another distal RV gene, 
Cdh6. Although we detected the up-regulation of CDH6 at day 8, we were not able to observe 
NOTCH2 expression. Instead, NOTCH1 expression was recorded. Chen et al. report strong 
Notch1 expression in capillary loop vascular wall including glomerular mesangial and 
endothelial precursors, whereas nothing was detected in the podocytes (Chen and Al-Awqati, 
2005). Interaction of the highest up-regulated genes reveals their heavy interdependence in 




Figure 23: Mesenchymal epithelial transition of MM to renal vesicle stage. Heatmap showing the expression 




Figure 24: Expression of the desired genes mapped as per their occurrence in embryonic mouse kidney 
development (Georgas 2009).   
 
 
Figure 25: (Left) Interaction of highly up-regulated genes on day 8. (right) Segmentation genes of RV 




Distinct cell-populations form after polarization and these produce the different segments of 
the adult nephron; a Wt1+ cell population gives rise to proximal structures, a Jag1+ population 
to the medial part and Lgr5+ cells generate the distal nephron segments. The strong evidence 
of segmentation prompted us to investigate protein localization of 3 of these genes WT1, JAG1 
and LGR5, in day 8 cells (Fig.25). Indeed their presence was detected but with no particular 
pattern of organization as observed in vivo. 
Thus, the cell mass obtained at day 8 is poised to segment and elongate into different 
compartments of the nephron together with ureteric epithelia primed for collecting duct 
formation. 
 
4.2.4. Autonomous renal precursor interactions lead to development of kidney 
organoids. 
After completion of 4 days of AB4RA and 4 days of GDNF treatment, cells were rested without 
medium change for 2 additional days. This resulted in the spontaneous appearance of compound 
structures spanning 200-500 µm with multiple columnar epithelial rings (50-100 µm) bounded 
by a common basal membrane (Fig.28). While in the case of WA01- ESC by the end of 8 days 
of induction, for the IMR90- iPSC- line, these structures appeared only when the day 8 cells 
were left in culture for 2 more days without dissociation into single cells. These structures were 
classified as organoids and occurred on an average at a rate of 6 organoids per cm2 (n=5) for all 
cell lines. Thus, the ESC at day 8 and iPSC at day 10 seem to be equivalent in developmental 
maturity. 
In order to understand why the spontaneous event of organoid formation happened in the case 
of ESCs on day 8 while at the same time point the iPSC lines did not form organoids, we 
investigated the gene expression. Comparing the gene expression of ESC- derived day 8 
organoids to the same set of genes discussed before, spanning between MM to a polarized renal 
vesicle, we found interesting patterns (Fig.26).   
The organoids showed the highest expression of WNT9B, BMP2 and BMP7, which are all 
required for inducing CM and its priming for epithelialization. Furthermore, all day 8 cells 
shared the high expression pattern of LEF1, WNT4, NOTCH1, JAG1, CDH6 and HES5. 
Although the pattern was similar, the organoids show a higher tendency of genes responsible 
for a more medial and distal segment of the nephron. Prominently, the set of genes grouped 




Figure 26: Mesenchymal-epithelial transition of MM to renal vesicle stage in organoids. Heatmap showing the 
expression pattern of major genes involved in pre-tubular aggregate formation and RV development during the course 
of organoid formation obtained by RNA-Seq. 
 




Interestingly, even though most genes correlated to nephron segmentation, a synchronous 
occurrence of EYA1-PAX8 and HOXD9 hints at the possibility that a lingering metanephric 
progenitor population can probably act as a source of nascent nephrons as the previous ones 
mature. As the orchestration of the EYA-PAX-HOX was observed in the organoids (Fig.26), 
they were compared to MM cells of day 4 (Fig.27). As seen previously, the renal vesicle 
associated WNT and segmentation genes were higher than day 4. Importantly, OSR1, OSR2, 
SIX1 and SIX2 were down-regulated but UB related genes HOXB7, GPC3, SHH and PTCH1 
were up-regulated. Shh is secreted from the medullary collecting duct and ureteric stalk and 
signals to the Ptch1 receptor in the surrounding interstitium (Yu et al., 2002). A rather regular 
expression of HOXB7 in the pseudostratified epithelium of organoids was seen using 
immunofluorescence (Fig.28). The manifestation of AGTR2, ANGPT1 and ANGPT2 together 
with a higher expression of PDGFA, B and D suggests a tendency towards mesangial and 
vascular differentiation.  
 
An abundance of the nephronal segmental genes in the organoids highlights the question if 
signatures of mature nephrons are present. Gene expression data of ESC-derived organoids 
present high FPKM values of AQP3 and Na+/K+ ATPase reflected by the reactivity to Lotus 
tetragonolobus Lectin (LTL) and Cytokeratin18 (CK18/KRT18), known to have a high affinity 
to proximal tubules and whole nephron respectively (Fig.28 E,F). Occurrence of Laminin 
indicates the formation of basement membranes in these structures. Thus, kidney organoids 





Figure 28: Organoid-like structures after 10-days of-AB4RA-G treatment on hPSCs. A, B- Phase contrast images, 
C- Hoxb7 stained nuclei of the organoid, D- higher magnification of C; E- Lotus lectin stained organoid, F- Organoid 
showing regions of Laminin (green) and Cytokeratin 18 (CK18 in green). C-F were obtained by multi-photon 







4.3. hPSC-derived renal progenitors give rise to constituent cell types of the nephron 
in vitro – 
 
4.3.1. Day 8 cells associate with reorganizing embryonic mouse kidneys 
A classic method to demonstrate the renal competence of a progenitor population in question is 
to test for functional integration into kidney tissue(Takasato et al., 2014; Xia et al., 2013). In 
this assay, embryonic kidneys of mice were used that characteristically reorganize themselves 
after dissociation into single cells when cultured in an air-liquid interface (Fig 29: A). To test 
this with the progenitor cells generated by the AB4RA-G protocol, we condensed day 8 renal 
differentiation cells into a pellet together with dissociated e12.5 mouse kidney cells. After 4 
days, tubular connections formed that ramified the aggregate (Fig.29: E, F) containing islands 
of human cells among murine embryonic kidney cells (Fig.29: G, H). Thus, day 8 precursor 
cells are successful in giving rise to nephronal aggregates in the absence of external induction 
factors. 
4.3.2. Nephron developmental programs advance in RV-like cells without the 
requirement of external elements. 
Molecular and immune-histochemical analysis of day-8 cells, indicate their poised state for 
nephronal development. To elucidate their inherent potency to generate different lineages of 
the nephron, day 8 RV-like cells were allowed to differentiate in the absence of induction 
factors post dissociation. Pellets of dissociated day 8 cells were prepared and placed on a trans-
well membrane, an air-liquid interface facilitating movement of solutes through a membrane. 
The specific transport properties of epithelia are accomplished by the expression of proteins 
(co-transporters, exchangers, channels) governing the movement of ions on either cell side 
(Bachmann et al., 1999). Five days of pellet culture resulted in a 3D tubular network of cells, 
which showed the presence of transporters characteristic of the different tubular compartments 
of the nephron (Fig 30). Enriched occurrence of AQP1+ and Na/K-ATPase+ indicated the 
presence of proximal tubule-like cells. Also present were SLC12A3 (Sodium chloride 
transporter-NCCT), characteristic of the distal part of the nephron tubule, and UMOD (Tamm 
Horsfall protein-THP), which is a protein localizing to the thick ascending loop of Henle. This 
experiment demonstrates the potency of day 8 cells to spontaneously generate three types of 
nephron epithelia with characteristic transporters without the requirement of external stimuli 




Figure 29: Embryonic mouse kidney re-aggregation assay with PSC-derived cells A, B: show phase contrast images 
of control E12.5 mouse kidney and a mixture of E12.5 mouse kidney cells and PSC-derived renal cells re-aggregated 
after dissociation. C, Confocal microscopy of aggregates reveals the presence of few human cells (Celltracker-Green) 
integrated, but no definite kidney structure as in (D) E12.5 mouse kidney aggregate showing the presence of a ductal 
tree and surrounding tubular bodies E-F:Phase contrast and fluorescence image of the chimaeric re-aggregation 
containing PSC.-derived renal cells (Celltracker-Green). And G, H: Confocal microscopy delineating the formation of a 
tubular network by human cells separate from non-green mouse cells. 
 
 
Figure 30: Tubular epithelium formation in pellet culture. Whole-mount immunofluorescence staining of Day 8 
cells cultured as a pellet for 5 days in DMEM-FCS shows(A,B) proximal tubular epithelial markers: AQP1 and Na/K-
ATPase and (C,D) distal tubular epithelial marker SLC12A3 and Loop of Henle marker Uromodulin expressing cells 
forming networks in a heterogenous mixture. Scale = 50µm.  
 
A B C D 
E F G H 
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Evidence from these experiments suggests that RV-cells can be steered with specific growth 
factors to obtain individual nephron constituent cell types spanning from the glomerular 
compartment to the entire tubular compartment until the collecting ducts that merge to form the 
ureter.  
 
Figure 31: Progress in embryonic development . 
 
4.4. Steering the differentiation of RV-like day 8 cells results in terminal cell types of 
the kidney: 
A screen for the most suitable growth factors and extracellular matrices promoting kidney cell 
formation was performed to direct differentiation of day 8 cells into different terminal renal cell 
types. (Experimental design described in Methods section). Using APEL medium as the base, 
we added factors like HGF, BMP7-FGF and LiCl; additionally we used REGM for our 
screening. HGF is known to induce tubular elongation in the case of ureteric and tubular 
epithelia(Santos and Nigam, 1993), LiCl has been known to effect WNT induction leading to 
tubular epithelial development (Davies and Garrod, 1995). Renal epithelial growth medium has 
been well documented to promote selective the growth of epithelial cells due to the presence of 
EGF, hydrocortisone and epinephrine (Taub and Sato, 1979). While all these factors were 
chosen to induce differentiation we used one combination with BMP7-FGF2 to maintain 
nephron progenitors(Dudley et al., 1999). Among the matrices used, recombinant h-Laminin 
521 provided the best cell morphology and hence was used for all further experiments (Fig.32). 
 
Figure 32: Morphology of human iPSC-derived renal progenitor populations on various extra-cellular matrix 
components
The cells resulting from treatment of the above-mentioned factors led to representative cells of 
the glomerular and tubular parts of the nephron and are described in detail in the following 
section. 
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4.4.1. Deriving cells of the glomerular compartment of the nephron:  
4.4.1.1. Mesangial cells. 
Six days of multi-factor treatment screen of the day 8 cells resulted in cells expressing alpha 
smooth actin (ASMA), platelet-derived-growth factor receptor ß (PDGFRB) and DESMIN 
(Lindahl et al., 1998) (Fig.33). The best performer among the three media was BMP7-FGF2, 
although HGF also induced considerable mesangial cells. Contrary to our hypothesis and 
currently available information that BMP7 and FGF2 prevent the differentiation of the 
metanephric cell population, we observed a successful differentiation of day8 cells with a high 
efficiency of generating a mesangial population. The fact that, day 8 cells are more 
representative of RV rather than an induced MM could attribute to selection of such a cell fate.  
Interestingly, the origin of mesangial cells and pericytes is not the SIX2+ nephronal progenitor 
but a Foxd1 population, responsible for generating non-epithelial cell fates in the adult kidney 
including renal erythropoietin-producing cells, identified by their close association with non-
glomerular and glomerular vasculature, respectively, and the expression of smooth muscle 
actin(Humphreys et al., 2010). Therefore, the occurrence of mesangial-like cells indicates the 
emergence of stromal cells as a result of the AB4RA-G induction verified by RNA-Seq (Figure 
34). 
 





4.4.1.2. Podocyte precursor cells  
When day 8 AB4RA-G induced renal precursor cells were plated at a low density in the 
presence of hepatocyte growth factor (HGF), they acquired an arborized cell body with 
undivided nuclei indicative of a podocyte-like phenotype. Around 70% of the cells were 
PODOCALYXIN (PODXL1) positive, expressing SYNAPTOPODIN (SYNPO) and WT-1 
(Fig.34) but failed to express NEPHRIN (NPHS1) in the areas of cell-cell contact.  
The proximal RV marked by WT1 gives rise to the glomerular epithelium, the presence of 
which was already noted at day 8 in the parent cell population. The progressive occurrence of 
transcription factors like SULF2, MAFB and MAGI2 between day 8 and day 14 at the RNA 
level presents evidence of the cells being specified to the podocyte lineage (Fig.34). Mafb 
observed in the S-shaped bodies (SSB) at E13.5, at this stage of development the immature 
podocytes form a single layer of cells adjacent to the glomerular cleft making it an excellent 
early podocyte marker (Brunskill et al., 2011). These cells also begin to express high levels of 
VEGFA, which at the SSB stage is capable of attracting an angioblast population from the 
surrounding interstitium to form glomerular capillaries. An elegant series of mutants that varied 
Vegfa protein production in podocytes highlights the critical role of Vegfa signaling in forming 
the capillary bed (Eremina et al., 2003, 2007) 
The reason for the immature state of podocytes could be attributed to a down-regulation in WT1 
from day 8 to day14. Further analysis into the regulators of this master transcription factor 
revealed a decrease in downstream targets like PAX2-8 and a parallel increase in negative 
regulators like PRDM1 and NROB1 and WNT4 (Figure 35). Thus, in order to improve 





Figure 34: Terminal differentiation of renal progenitors to podocyte precursor cells. a) Scheme for podocyte 
differentiation. b) Immune fluorencence staining of podocyte markers –SYNPO, WT1 and PODXL c) Heatmap showing 
the onset of podocyte development genes during the course of AB4RA-G followed by HGF treatment. 
 
Figure 35: Regulation of WT1 during the course of differentiation. RNA- seq data revealed the expression pattern 
of transcriptional regulators of WT1, the interactions of which were mapped using STRING10 DB (Credits: Ana Garcia) 
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4.4.2. Cells of the tubular compartment of the nephron 
At day 8, cells were harvested, plated as single cells at high density on Laminin-521 and 
stimulated with renal epithelium growth medium (REGM) and different combinations of 
growth factors to trigger further differentiation. After 6 days of continued culture in REGM 
(day 14), the cells formed epithelial domes and tubular rings (Fig. 36). Closer analysis at day 
14 revealed the presence of several types of tubular epithelial cells (T.E.Cs). 
  
Figure 36: Terminal differentiation of renal progenitors to tubular epithelial cell types. Morphology of cells after 
14-days imaged using brightfield microscopy and scheme of tubular differentiation. 
 
4.4.2.1. Proximal tubular epithelial cells 
The proximal tubule epithelial cells are characterized by brush border epithelial cells, which 
are highly absorptive. They possess several solute transporters and enzymes on their apical and 
basal surfaces that rule their functionality. Cells obtained at day 14 and their predecessors at 
Day 8, day 6 and 4 were checked for expression levels of proximal tubule markers obtained 
from literature. The onset of markers like ATPBP1and AQP1 can be observed starting at day 8 
and being sustained until day 14. The higher expression of CUBN, TJP1, and LRP2 at day 8 is 
noteworthy (Fig.37). Occurrence of Sodium/Potassium ATPase (Na+/K+ ATPase), Aquaporin1 
(AQP1) and Lotus lectin stained cells indicated a proximal-tube epithelial cell-like (PTECs) 
phenotype of these cells (Fig.37). AQP1+ cells constitute 57% of the tubular epithelial cell mass 





Figure 37: Proximal-tubular epithelial characteristics of Day 14 PSC-derived T.E.Cs. Heatmap of indicating the 
onset of proximal tubular epithelial genes during the AB4RA-G followed by REGM treatment protocol obtained from 
RNA-seq data. Bottom panel) Immune fluorencence staining of nephronal markers reveals proximal-tubule-like cells 





Figure 38: Distal-tubular epithelial characteristics of Day 14 PSC-derived T.E.Cs. Immune fluorencence staining of 
nephronal markers reveals distal-tubule-like cells and collecting duct cells; Efficiency of generation of AQP2+ cells 
(Principal cells).  
 
Figure 39: Differential expression of genes regulating ureteric tree formation during 14 days of differentiation. 






4.4.2.2. Distal epithelial cells 
Stemming from the distal part of the JAG1+ RV, the loop of Henle and distal tubule are 
responsible for concentrating urine. Sodium chloride co-transporter (NCCT/SLC12A3) and 
Kidney-specific cadherin (CDH16) were expressed in a minor population, revealing the 
existence of distal epithelial like cells (Fig.38). The tubular rings formed in culture (Fig. 36), 
bear a close resemblance to the cross-section of distal tubules in vivo. 
 
4.4.2.3. Collecting duct cells 
The presence of HOXB7, WNT11 and SOX9 expressing cells lead us to expect cells of 
collecting duct-like identity (Fig. 39). Indeed, within the T.E.C were cells expressing CLDN4, 
CLDN8 and GRHL2. A distinctive clear zone of cobblestone-shaped aquaporin 2 (AQP2) + 
cells co-expressing grainy head-like 2 (GRHL2) and Dolichos biflorus (DB) lectin indicated 
the presence of collecting duct constituents i.e. principal-like cells (PC) (Fig. 38). 
 
In summary, we were able to show the derivation of 5 nephronal cell types and organoids from 
AB4RA-G treated cells in 14 days, using novel induction factors (Fig.40). 
 
 








5.1. In vitro recapitulation of organogenesis: 
We have developed a novel chemically defined protocol for the directed differentiation of 
hPSCs toward the renal lineage. Broadly, we divide the protocol into three stages to incorporate 
the transient enrichment of intermediate mesodermal cell populations known to precede 
metanephric kidney formation. A first 4-day exposure to activin A, BMP4 and retinoic acid, 
generating IM, UB and MM forms the basis for a second step lasting 4 days of GDNF leading 
to nascent nephronal progenitors of the RV and CSB stage. This protocol is highly efficient, 
resulting in nephrogenic cells of which 70–80% expressed the transcription factor SIX2, 
characteristic of the MM in three different iPSC lines. A third step steered the renal progenitors 
towards terminal differentiation, an evidence of their potency to generate kidney cells 
representative of the major nephron segments. These include glomerular podocyte precursors 
and mesangial cells, together with proximal and distal tubular epithelial cells, collecting duct 
cells and the all-encompassing nephron organoids. 
 
We consider that optimization of stage 1, priming the cells for later signaling cues, was the most 
crucial step in developing an efficient differentiation protocol, because as in preliminary 
experiments it had the most influence over the final cellular phenotype. During embryonic 
development, agonists and antagonists of the activin-BMP4 pathways establish signaling 
gradients across the embryo, resulting in the specification of appropriate germ layer populations 
and derivative tissues (Agius et al., 2000; Gadue et al., 2006; Gritsman et al., 2000; Kubo et al., 
2004; Ladd et al., 1998; Lowe et al., 2001; Schultheiss et al., 1997; Thisse et al., 2000). Several 
groups have applied stepwise protocols drawing on this understanding of embryogenesis to 
generate nephrons from human PSCs in vitro (Freedman et al., 2015; Morizane et al., 2015; 
Sharmin et al., 2015; Taguchi et al., 2014; Takasato et al., 2015). A variety of culture formats 
and media have been used, yet they require the activation of a relatively small number of growth 
factor signaling pathways, with all protocols exploiting canonical WNT and FGF signaling, as 
the initial mesodermal patterning events involve canonical Wnt signaling with or without 
activin A and BMP4. With the exception of Freedman et al.(Freedman et al., 2015), all protocols 
induce intermediate mesoderm via the addition of FGF2 or FGF9 (Little, 2016).  
 
In contrast, our experiments show that in combination with activin A and BMP4, WNT is less 
effective than RA in inducing a primitive streak followed by IM establishment, as the former 
79 
 
favors an endodermal fate. This is consistent with a report from Tan et al., who observed that a 
GSK inhibition of hESC for more than 24 hours resulted in enrichment of CXCR4+ endodermal 
cells(Tan et al., 2013). Our data shows an increase in the much required FGF and WNT 
signaling in cells as an induced effect of the AB4RA combination, proving their activation 
without the need for exogenous addition. The involvement of activin A and BMP4 is necessary 
for primitive streak formation and the RA creates a morphogenetic gradient which promotes 
caudalization, inducing the generation of anterior and posterior IM in cell culture, which 
Taguchi et al. demonstrate elegantly to be the origin of UB and MM respectively (Taguchi et 
al., 2014).  
 
A sum total of all these signals yielded a majority of IM, nephric duct cells and an un-induced 
nephric mesenchyme in association with minor populations of paraxial and lateral plate 
mesoderm as indicated by gene expression. Although other reports of nephronal differentiation 
insist upon a high yield of IM generation being crucial to obtaining kidney cells of high purity, 
we hypothesized that a heterogeneous mixture of mesodermal cells will contribute a signaling 
milieu more representative of embryonic interactions promoting better developmental 
progression of the renal lineage.  
 
Subsequently, in our second stage of differentiation, we added GDNF, which is produced by 
MM cells and is an inducer of nephric duct cells to form UB. As expected this increases the UB 
formation and works to strengthen the feed-forward loop of GDNF secretion of MM cells 
enriching these populations within 48 hours. The developing UB activates the MM leading to 
the formation of CM and its subsequent epithelialization to form renal vesicle cells with signs 
of polarization. By day 8 of differentiation we see the occurrence of cells representative of the 
proximal, medial, distal nephronal segments and the ureteric tree. The derivation of UB in 4 
days (Xia et al., 2013), MM in 14 days (Taguchi et al., 2014) and both MM and UB in 18 days 
(Takasato et al., 2014) has been reported by other groups. We see the appearance of MM and 
UB as early as 4 days and their activation by day 6, which by far is the fastest induction of 
nephrogenesis reported to date. Takasato et al. also observed the presence of RV on day 18, as 
compared to our protocol that takes 8 days to show polarized RV state. A reason for the late 
appearance of epithelialization in the Takasato (2014) protocol can be attributed to the 
sustenance of FGF9 and BMP7 that support SIX2+MM in the stem state. In contrast, by 
maintaining the GDNF signal, we allowed the ureteric tree to develop, secreting WNT11 and 
WNT9B, which help in ureteric elongation and MM maintenance and activation, thus 
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illustrating the effectiveness of paracrine signaling and gradient formation within the cell 
culture system in response to growth factor treatment. 
 
The polarized RV is the first step toward nephron formation and specification of particular 
functional segments. Unattended culture of day 8 cells for 2-4 days led to spontaneous 
emergence of complex organized structures in culture that represented proximal and distal 
tubular elements that had developed lumen. Moreover, the organoids showed the presence of 
ureteric tree and endothelial markers. The afore-mentioned studies of nephronal differentiation 
also report the formation of spontaneously patterning and segmenting nephrons with proximal 
and distal tubular segments, as well as Bowman’s capsules, containing podocytes (Freedman et 
al., 2015; Morizane et al., 2015; Sharmin et al., 2015; Taguchi et al., 2014; Takasato et al., 
2015). These organoids are obtained by harvesting PSC-derived renal cells and pelleting, 
placing them in suspensions or matrigel sandwiches or transplanting them under the kidney 
capsule in a SCID mouse whereas, organoids in our culture arose spontaneously without any 
intervention and up to 10 days earlier than all current reports. Despite the advantages of a quick 
and simple derivation, the characterization and maintenance of these structures is yet to be 
optimized in our study. For instance, Takasato et al. show 3-D orientation of glomeruli attached 
to tubules that are connected to collecting duct epithelia and Freedman et al. managed to keep 
their organoids viable for about 60 days. This suggests that the organoids at day 10 require 
further signals for maturation and a culture system that is permissive of oxygen diffusion to this 
complex structure as well as allows the cells to establish nephron architecture. 
 
5.2. Procurement of the cellular building blocks of the kidney 
 
The ultimate goal of this study was to derive terminal kidney cell types. For this we harvested 
day 8 cells and subjected them to various growth factor treatments for 6 days. We obtained 2 
cell types of the glomerulus, namely mesangial cells and a nascent podocyte precursor by 
treatment with BMP7-FGF2 and HGF, respectively. From a different treatment using renal 
epithelial growth medium, we obtained tubular epithelial cells that were identified to be distinct 
proximal, distal and collecting duct epithelial cell populations. Kandasamy et al. derive 
proximal tubule (PT) cells within 9 days and are to-date the fastest to obtain a pure kidney cell 
population (Kandasamy et al., 2015). Song et al. derived podocytes from PSCs in 10-12 days 
but the protocol uses serum containing medium rendering these cells rather unfit for clinical 
application. Our protocol is unique in deriving at least 5 different terminal and 2 precursor cell 
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types in serum-free, xeno-free conditions and readily transferrable to GMP units and applicable 
for clinical use. Derivation of these cell types opens several topics of concern about their in 
vitro lifespan and functionality. In a number of cases, evidence supports a functional identity 
for component cell types within differentiation cultures, including the demonstration of 
appropriate uptake of albumin and response to nephrotoxins by the proximal tubular segments 
(Freedman et al., 2015; Morizane et al., 2015; Takasato et al., 2015). For large-scale expansions, 
it can be postulated that PSC-derived terminal cell types behave similarly to their in vivo 
counterparts with respect to low mitotic potential, necessitating the usage of larger quantities 
of PSC as starting material. These questions need to be addressed and present a good starting 
point for future experiments.  
 
Progressive differentiation to a terminal state is accompanied with a decreasing mitotic 
capacity. Therefore, although obtaining the 5 nephronal cell types mentioned above is a 
considerable achievement in the field of nephrology, these cell products do not offer a 
promising picture of regeneration in deteriorating kidney disease. A more suitable candidate for 
repairing damaged nephrons would be RV progenitors. Due to their segmentational identity, 
they can contribute to several parts of the nephron. A lineage tracing study by Rinkevich et al. 
shows that adult kidneys do not possess broad progenitor population catering to the complete 
nephron; rather, the adult kidneys contain segment-specific progenitors that are Wnt-activated 
(Rinkevich et al., 2014). Moreover, Takasato et al. also demonstrated that PSC-derived CM 
cells can be exposed to a pulsatile WNT signal give rise to complex nephron 
organoids(Takasato et al., 2015). This leads us to believe that RV cells treated with a short pulse 
of WNT-agonist constitute a putative cell therapy for acute kidney injury. Recent research by 
Lindstörm et al., illustrates the development of the nephron through formation of a ß-catenin 
gradient such that the lowest concentration determines the glomerular site and highest 
concentration induces distal tubules(Lindström et al., 2014). Further evidence of the differential 
requirement of ß-catenin was illustrated by the differentiation of in vitro propagated CITED1+ 
progenitors in WNT agonist-containing medium resulted in tubules with marker profiles of 
proximal, distal and intermediate segments but no glomerular cells(Brown et al., 2015). The 
Nishinakamura lab was successful in circumventing the lack of glomerular development by the 
recombination with embryonic spinal cord culture in congregation with the medium prepared 
by Brown et al., illustrating the need for additional cues in the differentiation medium albeit the 
exact factors secreted by the spinal cord remain obscure (Tanigawa et al., 2016). Thus, a defined 
differentiation medium for complete nephron formation is not yet available and would provide 
82 
 
further cues to understanding of pathways determining specific cell types during kidney 
development. While our protocol induces all structures through signaling events in a complex 
cell mixture, the exact drivers of factors and pathways involved in cell type specification are 
not yet determined. Successive targeting of single factors in our differentiation medium with 
pathway inhibitors or shRNA may be useful in deciphering their specific contribution. 
  
Candidates for regenerative therapies also include earlier progenitors such as MM and UB cells 
or IM, as they possess wider potential to contribute to nephrons. The application of IM for cell 
therapy can be challenging as it is a common precursor of the adrenal gland, gonads as well as 
the kidney, its multi-potency being a threat to ectopic tissue formation. As previously 
mentioned, Brown et al. developed a nephron progenitor expansion medium (N.P.E.M), which 
facilitated the first short-term of culture of E13.5 - 17.5 un-induced Cited1+ MM cells in vitro. 
Application of this medium on hPSC-derived nephron progenitors (Takasato protocol) showed 
their critical dependence on WNT, FGF9, SMAD inhibition and Rho-kinase inhibition, and 
allowed their expansion for 2 passages after which cells lost their identity (Brown et al., 2015). 
A more recent report shows that NOTCH inhibition and LIF are essential in maintaining 
nephron progenitors that retain potency to form both tubuli and glomeruli in embryonic spinal 
cord recombination experiments (Tanigawa et al., 2016). These studies present a first step in 
expansion and modulation of the fate of MM-nephron progenitors in vitro presenting the 
possibility of expansion and testing on various extracellular matrix scaffolds for generation of 
kidney tissues. Also crucial for all approaches of regeneration is the fact that a mature functional 
kidney finally requires a path to excrete urine from several glomeruli and tubules for which the 
presence of a collecting duct is inevitable. A protocol to expand and develop collecting duct 
trees form UB cells is yet to be designed. 
 
In summary, our protocol generates a wide spectrum of building blocks for kidney regeneration 
from PSCs. These cells can be used to repair injured kidney segments or used to reconstitute 
the whole kidney or nephron. The intricate architecture of the kidney plays a key role in 
establishing osmotic gradients and vascular connections required for normal functioning of 
nephrons. Acellular porcine kidney matrices offer a solution to kidney reconstruction, by 
providing positional cues that allow functional specification of PSC-derived progenitors. Bio-
engineering of individual nephrons to whole kidney may also be achieved by bio-printing the 
exact segment specific matrix with segment specific progenitors. Apart from being used in 
several combinations with extra-cellular matrices for tissue reconstitution, the terminal cells 
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can be used for drug screening and toxicity testing. Also, studying molecular mechanisms of 
genetic disease progression is an opportunity provided by PSCs as they can be derived from 
patients. Moreover, several key genes leading to fetal death on the occasion of mutations can 
be knocked down and studied in vitro during the course of development. Thus, PSC-derived 
kidney progenitors and cells provide a wide range of possibilities to understand and address 
issues in kidney biology and disease. 
 
5.3. Assembling kidney tissues from cells: The long road from organoids to organs 
 
A functional kidney consists of 200,000 to 2.5 million nephronal epithelial structures 
vascularized by blood vessels in a specific alignment with the surrounding interstitium and 
linked to the collecting duct to execute blood filtration, re-absorption and concentration of the 
urinary filtrate (Little, 2016). The closest as yet developed in vitro representative of such a 
complex organization of human cells, are the perfused repopulated acellular rodent kidneys 
(Song et al., 2013) and lab-generated PSC-derived organoids that contain representative 
portions of the kidney. Organoids are one step closer to mimicking the kidney than all individual 
terminal kidney cell types grouped together. While tubular segments of the nephron were 
common to all studies including ours, organoids with glomerular constituents in culture 
including non-associated podocytes and endothelial cells were reported only by the M.Little 
and Freedman labs (Freedman et al., 2015; Takasato et al., 2015). A key issue in encouraging 
the growth of organoids in vitro is the inclusion of vascular elements for circulatory support as 
well as developmental advancement. 
 
In the metanephric kidney, epithelial (Six2+Cited1+), endothelial (Flk1+/Scl/Tal1+), and 
stromal (Foxd1+) cellular lineages are confined within strict lineage boundaries, and therefore, 
a differentiation protocol aimed at enriching Six2+Cited1+ nephron epithelial progenitors will 
likely not include endothelial and stromal progenitors required to generate glomerular, 
endothelial, and mesangial cells. Accordingly, a human iPSC–derived cell suspension enriched 
for nephron progenitors and depleted for endothelial progenitors gives rise to vascularized 
glomeruli in vitro (Dekel, 2016). In our studies, a FOXD1 population was detected on exposure 
to HGF at day 14, which can be considered as the parent population of mesangial cells. Sharmin 
et al. showed the presence of vascularized glomeruli with interdigitating podocytes on 
transplanting the organoids under the kidney capsule of mice. In these experiments, the 
vascularization relied on host vessels growing into the grafted material. In order to avoid host 
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vasculature from penetrating the graft, Sharmin et al. attempted to exogenously add a mixture 
of non-renal human cells known to readily generate vessels to their induced cell suspension. 
Nevertheless, the latter failed to vascularize the iPSC–derived glomerular structures (Sharmin 
et al., 2015). It remains to be determined whether vascularization of PSC-derived glomeruli 
specifically requires the derivation of the cells responsible for glomerular vascularization in 
development (e.g., embryonic renal angioblasts residing in close proximity to nephron 
progenitors)(Dekel, 2016). Therefore, vascularization is essential for developmental maturation 
of cells and requires a separate compartment of renal progenitors that may not be favored by 
existing protocols. A solution to this problem lies in the modification of the protocol to enrich 
for vascular-stromal cells rather than an exogenous addition to the organoids. 
 
A built-in vasculature will also allow perfusion of organoids. An important component of the 
renal excretory process is the exchange of electrolytes based on the specific orientation of solute 
transporters throughout the tubular epithelium. A major factor governing the osmotic gradient 
is the apico-basal distribution of water and solute transporters. While PSC-derived renal cells 
do express these transporters, they lack polarized expression that can only be created under the 
influence of flow. By vascularizing the organoid, tubular segments would receive continuous 
input through their lumens on one side and can transport back excess solutes into the 
vasculature, a step forward towards urine formation.  
 
The in vitro maturation process generates renal structures mostly equivalent to those found in 
first trimester human fetal kidney (Takasato et al., 2015). For renal bioengineering and growing 
kidneys, it is noteworthy to mention that in vivo organogenesis of grafts of first trimester human 
fetal kidney led, at best, to formation of miniature kidneys producing dilute urine 2 months after 
transplantation, far away from what is expected from an adult kidney (Dekel et al., 2003). 
Therefore, essential tasks to create urine–producing functional miniature kidneys would be to 
extend renal maturation in vitro as much as possible and achieve induction and incorporation 
of ureteric bud–derived collecting ducts for possible urine drainage. Unlike other protocols that 
concentrate on MM-derivation, we induced MM and UB simultaneously, hence providing 
organoids with the necessary building material for drainage. Yet another critical aspect of organ 
function encompasses innervation and hormonal control, which are yet to be addressed in vitro. 
 
Altogether, the hazy road from bench to bedside is starting to clear up, with prominent 
milestones being the generation of renal progenitors and organoids from PSCs that can be 
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tailored for individuals. Lab-grown kidneys as transplantable material are a destination that 

































Table 15: Genes Involved in Kidney Development 
Developmental 
Process Gene  
Function  Expression in 
Normal Developing 
Kidney  
Mutant Kidney Phenotype 
(Mouse)  
Role played in organogenesis 
Reference  





around ureteric bud 
branches  
Reduced and ectopic ureteral 
branching, ectopic 
ureterovesical junction, 
hydoureter, double collecting 
ducts, hypo/dysplastic kidneys 




BMP7  Growth factor  Mesonephric duct, 
UB, iMM, DT, CSB 
and SSB, podocytes  
Increased apoptosis in 
metanephric mesenchyme, 
decreased ureter bud 
branching, hydroureter, severe 
renal hypoplasia  
(Dudley et al., 
1995; Luo et 
al., 1995) 
Brnl /POU3F3 Transcription factor  RV, CSB, SSB, LoH, 
DT, macula densa 
(MD) 
Disrupted differentiation of 
LoHs, MD, and DCT  
(Nakai et al 
2003) 
Cadherin-6  
(K-cadherin )  
Transmembrane 
adhesion protein  
RV, proximal end of 
CSB,SSB, 
developing proximal 
tubules and Henle's 
loops  
Delayed fusion of some 
comma-shaped bodies to 
ureteric bud leading to loss of 
nephrons  







distal portion of the 
nephron 
homotypic cellular recognition (Shen et al., 
2005) 






Irregular foot processes, absent 
filtration slit diaphragms, 
proteinuria  
(Shih et al., 
1999) 
Cited1 Transcription factor uiMM No mutant phenotype in kidney (Boyle et al., 
2008) 
c-Ret  GF receptor (TK) 
(receptor for GDNF 
)  
Mesonephric duct, 
UB and tips of UB  




Decorin (Dcn) Proteoglycan matrix 
component 
Stromal cells Antagonist of BMP7 (Fetting et al., 
2014) 
Etv4/5 Transcription Factor UB,CD Downstream of FGFR (Costantini and 
Kopan, 2010) 
Eya1  Transcription 
coactivator ( 
interacts with Six1 )  
IM, MM  Intact pro- and mesonephros, 
but absent metanephric 
blastema, renal agenesis  
(Li et al., 2003; 
Sajithlal et al., 
2005; Xu et al., 
1999) 
FGF-8  Growth factor  PTA, RV, tubule 
progenitors in SSB  
Increased apoptosis in S body 
precursors, truncated nephrons, 
severe renal hypoplasia  
(Grieshammer 
et al., 2005) 
Fgfr1,Fgfr2 Growth factor 
receptor 
UB,MM Required for RV formation Trueb 2013 
Foxc1/2  Transcription factor  IM, mesonephros, 
MM  
Double ureters with one a 
hydroureter, duplex kidneys ( 
Foxc1 / Foxc2 compound 
heterozygous mutants similar 
to Foxc1 homozygous mutants)  
(Kume et al., 
2000) 
Foxd1(BF2)  Transcription factor  Interstitial stroma 
cells  
Decreased ureteric bud 
branching, large mesenchymal 
condensates, abnormal renal 




GDNF  Growth factor  IM, mesonephros, 
iMM, PTA  
Ureteric bud fails to form or 
has abnormal branching, renal 
hypoplasia or agenesis  
(Sánchez et al., 
1996) 
GFRα1  GF coreceptor 
(forms signaling 
complex with 
GDNF and c-ret)  
iMM, PTA, 
mesonephric duct, 
UB and tips of UB  
Similar to GDNF-deficient 
mice  





    
Heparan sulfate 
proteoglycan  
All MM and UB 
derivatives  
Increased cell proliferation in 
cortical collecting ducts, 
increased apoptosis in 
medullary collecting ducts, 
renal medullary cystic 
dysplasia  
(Grisaru et al 
2001) 





duct, MM  
Ureteric bud forms but fails to 
invade metanephric 
mesenchyme, which undergoes 
apoptosis, renal agenesis  
(Michos et al., 
2004) 
Grhl2 Transcription factor ND, UB and CD Inactivation results in defects 
of epithelial barrier formation 
and lumen expansion 
Aue 2014 







IM,MM  Impaired ureteric bud 





Wellik et al., 
2002) 
Integrin α3 β 1  Transmembrane 
adhesion receptor  
UB,CD, podocytes  Decreased branching of 
medullary collecting ducts, 
microcystic proximal tubules, 
defective glomerulogenesis  
(Kreidberg et 
al., 1996) 
Integrinα8  Transmembrane 
adhesion receptor  
IM ,iMM, PTA  Limited ureteric bud invasion 
of metanephric mesenchyme, 
decreased ureteric branching, 
renal hypoplasia or agenesis  
(Müller et al., 
1997) 
Kif26b Intracellular motor 
protein 
uiMM Agenesis- uretic buds failed to 
invade and branch into the 
mesenchyme, resulting in 
disappearance of the kidney by 
embryonic day 14.5 
Uchiyama 2010 
Kreisler 
(Krml1/MafB )  
Transcription factor  Podocytes, initially at 
capillary loop stage  
Abnormal podocyte 
differentiation with no foot 
processes  
Sadl et al 2002 
Laminin α3ß 1  Transmembrane 
adhesion receptor  
UB,CD, podocytes  Glomerular capillary loops 
dilated and fewer in number, 
loss of podocyte foot 
processes, dual GBMs (failure 
of fusion)  
(Kreidberg et 
al., 1996) 
Lamininα5  Basement 
membrane protein  
Basement membranes 
of UB, developing 
tubules and 
glomerular basement 
membrane (GBM)  
Abnormal glomeruli with 
displaced endothelial and 
mesangial cells, and clustered 
podocytes  
(Miner and Li, 
2000) 
Laminin ß 2  Basement 
membrane protein  
GBM beginning at 
capillary loop stage  
Absence of podocyte foot 
processes, proteinuria  
(Noakes et al 
1995) 
Lim 1 /Lhx1 Transcription factor  IM, ND, 
mesonephros, UB, 
CD, PA, SSB, 
podocytes  
Absent pro-, meso-, and 
metanephros ( Lim 1 required 






Lmx1b  Transcription factor  Podocytes  Abnormal foot processes, 
absent filtration slit 
diaphragms  
(Chen et al 
1998) 
Neph1  Transmembrane 
protein (interacts 
with nephrin)  
Podocyte filtration 
slit diaphragm  
Foot process effacement, 
proteinuria  
(Donoviel et al 
2001) 
Nephrin  




slit diaphragm  
Foot process effacement, 
absent filtration slit 
diaphragms, proteinuria  
(Putaala et al., 
2001) 
Npnt Basal membrane 
component 
Embryonic kidney kidney agenesis or hypoplasia Linton 2007 





Abnormal glomeruli arrested at 
capillary loop stage, with 
disorganized podocytes and no 





Osr1 Transcription factor IM,MM Specifying IM that gives rise to 
MM 
(Mugford et al., 
2008) 
Pax 2  Transcription factor  IM,ND, 
mesonephros, UB, 
iMM  
Intact nephric duct but 
mesonephric tubules and 
ureteric bud fail to form, renal 
agenesis  
(Brophy et al., 
2001; Dressler 
et al., 1990) 
PDGF-B  Growth factor  Glomerular 
endothelial cells and 
podocytes  
Dilated glomerular capillaries 
with no mesangial cells  
(Leveen et al 
2004) 
PDGFR- ß Growth factor 
receptor (receptor 
for PDGF-B )  
Glomerular 
mesangial cells  
Dilated glomerular capillaries 
with no mesangial cells  
(Soriano, 1994) 




membrane domain  
Abnormal podocytes, foot 
process effacement, absent 
filtration slit diaphragms, 
anuria  
(Doyonnas et al 
2001) 






Irregular foot processes, absent 
filtration slit diaphragms, 
proteinuria  
(Roselli et al., 
2004) 
RARα, RARß 2  Transcription 
factors  
RAR± ”ureteric bud, 
metanephric 
mesenchyme, stroma  
RAR²2 ”stroma only  
Decreased ureteric bud 
branching (defective stroma 
signaling) in RAR ± / ² 2 




R-cadherin  Transmembrane 
adhesion protein  
iMM, RV, CSB,SSB  Dilatation and cytoplasmic 
vacuolization of proximal 
tubules  
(Shimazui et al 
2000) 
Sall 1  
    
Transcription factor  Mesonephros, iMM Ureteric bud forms but does 
not fully invade metanephric 
mesenchyme, which undergoes 
apoptosis, renal hypoplasia, or 
agenesis  
(Nishinakamura 






MM and CD  Ureteric bud forms but does 
not fully invade metanephric 
mesenchyme, which undergoes 
apoptosis, renal agenesis  
(Ruf et al., 
2004; Xu et al., 
2003) 
Six2 Transcription factor MM Agenesis and premature 
differentiation to nephrons 
(Kobayashi et 
al., 2008) 
Sox9 Transcription factor Ureteric tree Downstream of GDNF 
signaling; Required for 
Sprouty1 and Etv4/5 
expression 
Reginensi 2011 
Sprouty1  Receptor (TK) 
antagonist  
Mesonephric duct, 
UB and tips of UB 
Supernumerary ureteric buds, 
multiple ureters, multiplex 
kidneys  
(Basson et al 
2005) 
VEGF-A  Growth factor  SSB, podocytes, CD  Small glomeruli, lack capillary 
loops, few endothelial cells  
(Eremina et al., 
2003) 
Wnt11  Secreted 
glycoprotein  
UB tips  Loss of ureteric tips, reduced 




Wnt4  Secreted 
glycoprotein  
PTA, CSB, distal 
SSB  
Ureteric bud branching occurs, 
no mesenchymal-epithelial 
transition, renal agenesis  
(Tanigawa et 
al., 2011) 
Wnt9b  Secreted 
glycoprotein  
Mesonephric duct, 
UB,CD but not 
branching tips  
No mesenchymal-epithelial 
transition, renal agenesis  
(Carroll and 
Das, 2013; 
Karner et al., 
2011) 
Wt1  Transcription factor  IM, mesonephros, 
MM, CSB, SSB, 
podocytes  
Absent caudal mesonephros, 
ureteric bud fails to form, 
metanephric mesenchyme 
undergoes apoptosis, renal 
agenesis  
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ACE Angiotensin-converting -enzyme  
ADH Antidiuretic hormone 
AKI Acute kidney injury  
APEL Albumin Polyvinylalcohol Essential Lipids 
BIO (2ʹZ, 3ʹE)-6-Bromoindirubin-3ʹ-oxime  
BMP Bone morphogenetic protein 
CD 
Cluster of differentiation;  
Collecting Duct  
cDNA Complementary DeoxyriboNucleic Acid 
CKD Chronic kidney disease 
CM Conditioned medium 
DNA Deoxyribonucleic acid 
DAPI 4′, 6-diamidino-2-phenylindole  
DMEM Dulbecco´s Modified Eagle´s Medium 
dpc Days post coitum 
DT Distal tubule 
DTECs Distal tubular epithelial cells 
E mouse embryonic day 
EB Embryoid body 
EGF Epidermal growth factor 
ESRD End stage renal disease 
FGF Fibroblast growth factor 
FGFR Fibroblast growth factor receptor 
GDNF Glial-derived neurotrophic factor  
GUDMAP GenitoUrinary Development Molecular Anatomy Project 
hESCs human embryonic stem cells  
HFF Human foreskin fibroblasts 
hPSCs human pluripotent stem cells 
IM  Intermediate mesoderm 
iMM induced MM 
iPSCs induced pluripotent stem cells 
KEGG Kyoto Encyclopedia of Genes and Genomes 
LIF leukemia inhibiting factor  
LOH Loop of Henle 
LPM Lateral plate mesoderm 
MEF Mouse embryonic feeders 
MM Metanephric mesenchyme 
ND Nephric duct 
PBS phosphate-buffered saline 
PM Paraxial mesoderm 
PS  Primitive streak 
PT Proximal tubule 
PTA  Pretubular aggregate 
PTECs Proximal tubular epithelial cells 
PTH Parathyroid hormone 
RA Retinoic acid 
REGM Renal epithelial growth medium 
rh Recombinant human 
RNA Ribonucleic Acid 
ROCK Rho-associated protein kinase 
RV Renal vesicle 
TEC Tubular epithelial cells 
uiMM uninduced MM 
  
TREATMENTS 
AB4RA ActivinA, BMP4, Retinoic acid 
AB4F2 ActivinA, BMP4, FGF2 
AB4B7 ActivinA, BMP4, BMP7 
AB4BIO ActivinA, BMP4, BIO 




°C : degrees Celsius 
%: Percentage 
g: grams / gravity 
hr/hrs : hours 
kDa: kilo Daltons 









s: seconds  
U: units  
V: volt  
mIU: milli international units 
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